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Abstract
While titanium (Ti) and its alloys have become ubiquitous within implantology as materials to
restore or augment the function of human tissues, their success is plagued by complications
associated with infection and aseptic implant loosening. These two risks account for the majority
of implant failures in the clinic and limit the long-term success of titanium implants in vivo.
Therefore, this thesis describes the development of robust multifunctional class II organicinorganic hybrid coating materials for titanium implants that could be used to effectively target
both complications, concurrently. During this master’s work, two different coating systems were
examined. First, class II hybrid coating materials composed of chitosan and silica loaded with
silver nanoparticles were investigated. These coatings displayed a high resistance to fracture,
great substrate adhesion and inhibited the growth of two clinically relevant pathogenic bacteria
(E. coli and S. aureus) in both biofilm and planktonic cultures. Secondly, a novel class II hybrid
coating material was developed that was composed of polyethylene glycol, calcium, and silica
and loaded with silver nanoparticles. This hybrid bioactive glass material possessed similar
mechanical and antimicrobial properties to the chitosan-silica coatings and displayed an
increased bioactive response. From this study, a better understanding of the feasibility of class II
hybrid materials as implant coatings was developed. The work presented in this work may afford
a novel strategy in improving the success of implants for biomedical applications.
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Summary for Lay Audience
The use of titanium implant materials has become ubiquitous in the field of implantology. While
titanium-based implant materials possess adequate mechanical properties to meet the demanding
loading conditions of the human body, their interfaces fail to illicit positive physiological
responses. For this reason, implant surfaces become targeted sites for microbial colonization
(leading to infections) and are unable to promote the fixation of protheses (leading to loosening)
in the body. These phenomena (implant associated infection and aseptic loosening, respectively)
are the two major complications that affect the continued success of hard tissue restorations
today.
In consideration of these complications, this study provides a potential coating solution that can
synergistically prevent infection and promote the fixation of implantable materials. Using a
coating framework composed of similar inorganic contents to that of bone, positive physiological
responses can be promoted that encourage the fixation of the implantable devices within hard
tissues. By imbedding coating networks with antimicrobial silver nanoparticles, implant surfaces
could be afforded with infection-resistant properties.
This study also considered the factors attributed to the clinical translatability of developed
“multifunctional” implant coatings. Coating materials developed for hard tissue implants should
be robust. This means they remain adhered to the implant surface throughout its lifetime within
the body and are resistant to the impacts of various surgical tools and bony protrusions upon
implantation. Additionally, such coating materials should avoid the use of toxic chemicals or
network forming agents. This ensures that during the lifetime of the implant potential coating
degradation does not induce a toxic effect in the host.
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Chapter 1: Introduction
1.1 Overview
An implantable material (or biomaterial) is a biomedical device used to augment or restore the
function of human tissues. Over the past fifty years, the popularity of biomaterial-based
treatments has increased dramatically with more than 13 million devices implanted annually in
the United States alone1. Through advances in material science, biomaterials have become
increasingly tailorable to human physiology. This has led to a considerable increase in the
success of such materials in the replacement of damaged bone tissues.
Throughout this past half century, titanium (Ti) and its alloys have become the material of choice
for biomedical implants2,3. Their low specific weight, high strength to weight ratio, and
resistance to corrosion are features that make titanium the ideal bulk material for numerous
clinical applications4,5. These include orthopaedic and dental implants where their resistance to
chipping and capacity to endure repetitive high loading conditions are an advantage over nonmetallic substrates4,6,7. Furthermore, the titanium dioxide layer that forms on their surfaces are
highly inert and biocompatible to the cells and extracellular matrix of surrounding tissues.
However, along with the bio-inertia of titanium surfaces, is the lack of significant osteoinductive
or antimicrobial properties.
Currently, the surface modifications on titanium implants are limited commercially to surface
treatments (physical roughening, anodizing, chemical etching etc.), and inorganic ceramic
coatings that typically incorporate hydroxyapatite (HA) as a bioactive layer. However, the
application of ceramic coatings involves numerous disadvantages such as slow processes, high
temperatures (biomimetism, plasma spraying), overly thick or weak film deposition, brittle
substrates, and their inability to be loaded with temperature sensitive antimicrobials8–10.
Therefore, there has been significant interest in using alternative coating materials that consist of
a larger organic content, which would improve their material properties while retaining an
adequate level of bioactivity in tissues.
Given the limited success of commercially available coating materials, the development of
multifunctional implant coatings, capable of providing osteoconductive interactions with native
interfaces while also providing antimicrobial activity have been increasingly sought after. To this

1

end, the development of class II organic-inorganic hybrid materials that retain the biological
benefits of polymers such as chitosan and PEG, while enhancing their physical properties, has
been proposed11–13. The covalent coupling of biopolymers to inorganic precursors is the focus of
this thesis and is the framework of multifunctional coating materials evaluated in this study.
1.2 Thesis Objectives
Considering the limited success of bare and plasma coated titanium implant materials, the overall
focus of this study was to synthesize robust coating materials on titanium substrates to improve
on their overall success in vivo. Coatings developed in this work should greatly improve on the
shortcomings of current bare and plasma coated titanium implant materials.
1.3 Hypothesis
It is hypothesized that the integration of silicon (Si) and calcium (Ca) into the coating network
will act to improve the overall robustness of coating materials, and, will promote factors
associated with osseointegration. Additionally, it is hypothesized that the addition of silver
nanoparticles (AgNP) into the coating network will provide an antimicrobial effect against
sessile and biofilm colonies of clinically relevant pathogenic bacteria.
1.4 Thesis Outline
As highlighted above, the objectives and hypothesis of this study focuses on the development of
robust bioactive and antibacterial coating materials for titanium implantable devices. Chapter 2
provides a comprehensive review of the relevant literature in this area. Chapter 3 includes the
synthesis and discussion of a robust chitosan-silicon class II hybrid coating materials to improve
the antimicrobial efficacy of titanium implants. Chapter 4 includes the synthesis and relevant
discussions related to the development of a robust PEG-Si-Ca class II hybrid coating to promote
osseointegration while providing an antimicrobial effect. Chapter 5 provides a discussion on the
relevant conclusions to this study and suggestions for future work.
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Chapter 2: Literature Review and Background
While established as a field of scientific study in the 1960s, the use of biomaterials pre-dates
ancient times. Evidence of foreign material usage as implants or protheses has been found in the
excavation of ancient burial sites of ancient Egyptian, Roman, Greek and Etruscan civilizations1.
Since these primitive designs, biomaterial implementation has been improved through
industrialization, advances in material and polymer chemistry, and an increased understanding of
the foreign body response to biomaterials.
2.1 Hard Tissue Implants
Since antiquity, hard tissue implants have found great use in the restoration and augmentation of
diseased or damaged tissues. In general, hard tissue implants are prosthesis that are integrated
with hard tissue systems in the body such as bones, joints, and teeth. In present day, these
prostheses are predominantly made of metallic or ceramic materials that have sufficient chemical
and mechanical stability to achieve successful integration and long-term stability with host
tissues. The application of hard tissue implant materials finds greatest use in the fields of
orthopedics and prosthodontics.
Orthopedic implants exist in many physical forms and can be used in a variety of restorations
such as joint arthroplasty (hip, knee, and shoulder) and the repair of fractures to other osseous
tissues (some shown in Figure 2.1)2. Surgical interventions and implantations have become
increasingly more common in this area due to the increased rates of osteoporosis and arthritis
among older populations2,3. Often large orthopedic restorative surgeries, such as total hip
replacements, require special attention to the type of implant materials used. Consideration for
material properties such as elastic modulus, hardness, and fatigue resistance have been shown to
prevent long term complications associated with these load bearing implants such as stress
shielding and wear3,4. Other devices used in orthopedics include small, and non- or low-load
bearing implant materials that include screws, pins, plates and meshes. These materials are often
used as internal or external fixation devices which can maintain the alignment of bone fragments
or material substitutes during the healing process5. During the application of these fixation
devices, compressive force is often used to lower stresses placed on the implant and increase the
contact area at repair sites5. Given that these devices are under significantly lower stresses than
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larger orthopedic implants, procedural complications are more frequently associated with
infection rather than stress shielding and wear.

Figure 2.1 Examples of implant forms used for hard tissue implantation in orthopedics. Adapted
from Rony et al.6
In prosthodontics, dental implants are most commonly used as supports for artificial tooth
replacements. The use of dental implants has increased dramatically in the past 30 years, limiting
the need for non-fixed dentures and bridges to replace lost teeth in many cases7. Implants in this
field exist in a variety of physical forms such as screws, cylinders and blades, with the most
common structure of complete dental prosthesis following a screw-abutment-crown design
(Figure 2.2)8. Here, screw-like devices are directly implanted into the maxilla or mandible which
acts as an anchor for artificial teeth (crowns). Abutments are then used to connect the crown to
the screw anchored in the patient’s jawbone9,10. Similar to the field of orthopedics, dental
implants are used for both load bearing and low-load bearing applications which are determined
by their placement in the oral cavity11. The success of these implants is determined by the
successful fixation of screw supports implanted within the jawbone and their ability to resist
infection. Failure modes of these implants have been attributed to low bone density in the
maxillofacial region and implant sepsis due to the contaminated surgical field within the oral
cavity12,13.
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Figure 2.2 Screw-abutment-crown dental implant design. Adapted from
www.1888implant.com14
In both orthopedic and prosthodontic implant interventions, the choice of material is a critical
determinant to the overall success of the restoration. Titanium represents a large portion of these
bone-interfacing biomaterials given its superior mechanical properties and proven ability to
interface well with human tissues.
2.1.1 Titanium Implants
Metallics have been the choice implant material since the advent of aseptic surgical techniques15.
Since then, metallics have found many uses as orthopedic and prosthodontic implant materials.
Commonly used metallics in these areas include stainless steel (SS), cobalt-chromium alloys
(CoCr), and titanium alloys (Ti). Of which, SS and CoCr have lost favour in many applications
due to their lack of performance in comparison to titanium alloys. Titanium based implants
possesses advantages over these metallics in terms of their rate of corrosion, modulus value, and
biocompatibility.
The corrosion of metallic implants leads to the release of metallic ions from the bulk material.
The release of these cationic species affects surrounding tissues by modifying their electrical and
chemical environment which can produce a degree of cytotoxicity16,17. While all metals corrode
to some extent in vivo, choice materials are those that corrode in a slow and controlled fashion18.
For this reason, SS and CoCr implant materials have lost favour in many applications as they
readily corrode in physiological environments. The corrosion of SS an CoCr, along with
modifying the surrounding physiological environment, leads to a cytotoxic effect attributed to
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the leaching of cytotoxic elements such as nickel, chromium and cobalt19. Titanium based
materials, however, exhibit a high resistance to corrosion. Additionally, when alloyed, titanium
based materials can contain relatively non-toxic elements such as magnesium niobium, tantalum,
and zirconium leading to minimal cytotoxicity during corrosion20,21. Titanium and titanium
alloys display increased resilience to corrosion due to the formation of an oxide layer in the form
of TiO2, Ti2O3, TiO and TiO222,23. This film, while robust, also possesses self healing properties
in vivo due to the reactive nature of titanium. Any disruptions or damages to the outer oxide layer
are repaired immediately in environments with air or oxidizing media such as physiological
fluids.

Additionally, SS and CoCr based implant materials have relatively high modulus values
compared to that of bone (Figure 2.3)24. High modulus mismatches between implant materials
and host bony tissues have been shown to cause a condition known as stress shielding. Stress
shielding is a process in which high modulus implant materials prevent host tissues from being
exposed to normal levels of mechanical loading25. In cases where stress shielding occurs, host
bony tissues around the implant are remodeled, leading to a decrease in bone strength, cell death,
and subsequent implant loosening26,27. Unlike SS and CoCr materials, titanium alloys can
possess similar moduli to that of bone, leading to a decrease in the severity of stress shielding.
The decreased effect of stress shielding becomes quite relevant in the comparison of different
metallics used as high load bearing implant materials. In the case of total hip replacements,
studies have shown that femoral stem materials made of titanium alloys, as opposed to higher
modulus materials such as CoCr and SS, led to less femoral bone loss and better integration with
host tissues28–30.
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Figure 2.3 Modulus of elasticity of commonly used implant metallics. Adapted from
Geetha et al.24

In addition to being more resistant to corrosion and possessing improved mechanical properties
to other metallics, titanium materials are also more biocompatible. While no surgical study of
metallic implants is completely free of adverse reactions, titanium implant materials have been
shown to be well tolerated as an inert material in the human body. When compared to SS and
CoCr alloys, titanium implant materials exhibit superior biocompatibility, akin to their decreased
cytotoxicity and decreased levels of fibrosis upon implantation20,24,31. The increase in relative
cytotoxicity and fibrosis of SS and CoCr implant materials have been owed to the release of
metal ions upon corrosion and their lack of relevant topographical cues32,33.
Despite the superior performance of titanium-based implant materials relative to other metallics,
they are still continuously subjected to various surface modifications in order to better function
with the human body. The development of appropriate surface topographies and coating
materials has represented a large portion of research in implantology in recent years and has been
a challenging problem in the field of metallics in general. The interface of implant materials has
become a key factor to combat the complications faced in this field and, overall, increase the
longevity and fixation of implants in the human body32,34–36.
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2.1.2 Implant Complications
2.1.2.1 Implant Associated Infections
One of the main problems that continues to limit the success of hard tissue implant interventions
is implant associated infection (IAI). Orthopedic fixation devices, particularly external fixation
devices, have notoriously high rates of post-operative infection, occurring in 5 and 30% of all
internal and external interventions respectively37,38. The infections of dental implants are also
significant with IAI occurring in 5-10% of all implant procedures39. While virtually all bacteria
and fungi can cause IAI, the most common bacteria responsible are the staphylococci species
including Staphylococcus aureus (S. Aureus) and Staphylococcus epidermidis (S.
epidermidis)40,41. The prevalence of such species can be owed to their natural residence within
the skin flora and their ability to form pathogenic biofilms on implant surfaces42.

Biofilms are highly adherent colonies of bacteria that are encased within a bacterial-excreted
polysaccharide matrix. The formation of biofilms occurs through several stages explained
visually through Figure 2.4. In this process, planktonic species of bacteria adhere to a surface and
then begin to proliferate and adhere to adjacent colonies through the release of extracellular
polymeric substances (EPS). Mature biofilms encased in EPS subsequently release planktonic
colonies within their matrix to continue the cycle. Additionally, mature biofilms present a
favourable environment for symbiotic microbes such as Escherichia coli and Pseudomonas
aeruginosa in the development of polymicrobial biofilms43. The formation of biofilms presents
major problems in combating IAI. First, the release of planktonic colonies from mature biofilms
leads to a chronic inflammatory state at the implant site, and, can lead to infection in other parts
of the body. Second, the bacteria within biofilms may be up to 1000 times more resistant to
antibiotics than bacteria that are suspended in a planktonic state44,45. In the antibiotic therapy of
biofilm infections, the high doses of antibiotics required to combat biofilms result in systemic
toxicity with associated renal and liver complications46,47. When low dose treatments are used,
therapeutic agents are often below the minimum inhibitory concentration (MIC) of biofilm
bound bacteria which increases the risk of developing antibiotic resistance pathogens48.
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Figure 2.4 Stages of biofilm formation on implant surfaces. Adapted from Chung et al.49

Due to the resistant nature of biofilms, the gold standard treatment of IAIs in orthopedics has
been two-stage septic revisions50. In this revision technique, the first stage involves the removal
of the prosthesis, followed by extensive debridement of all damaged or infected tissues. At this
stage, antibiotics are administered to patients and reimplantation is delayed until the completion
of an antibiotic regimen. In conjunction with this regimen, antibiotic-loaded beads or spacers are
typically inserted into the sites of larger infected prosthesis such as those used in total hip and
knee replacements51. Reimplantation in these cases includes the removal of antibiotic-loaded
beads or spacers before the placement of the new prosthesis. Septic revisions are technically
complex and require significantly more resources than initial prosthesis placements4. The
duration of these surgeries are longer, patient hospital stays are extended, and there are often
more complications related to these interventions. Despite this rigorous procedure, the initial
infection is not always completely eradicated which increases the chance of reinfection at the site
of reimplantation52. For example, in the case of total hip arthroplasty (THA), there is typically a
1-2% risk of infection for primary THA, whereas secondary septic revisions of THA carry risks
of infections as high as 17%51,53,54.

In the field of prosthodontics, IAIs are typically caused by the colonization of pathogenic
biofilms on the collar of dental implants. Biofilm formation on dental implant materials can
initially lead to infections of the peri-implant mucosa in a condition known as peri-implant
mucositis (PIM)55. PIM, which causes inflammation and damage of the peri-implant mucosa,
ultimately leads to the formation of soft tissue gaps around the implant. The formation of these
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gaps allows for bacteria to spread to regions where hard tissues are exposed. The exposure of
pathogenic bacteria to surrounding bone causes characteristic bone loss around the implant in a
condition known as peri-implantitis (PI)56. PI has been shown to be one of the main reasons for
the loosening and failure of dental implants57. Due to the placement of dental implants in
endosseous tissues and the prevalence of biofilm occurring mainly at the collar of dental
abutments, treatment methods typically do not follow the same septic two-stage revisions seen in
the field of orthopedics. In the treatment of dental implant infections a variety of surgical
(resective therapy, bone regeneration therapy) and non-surgical methods (abrasive cleaning,
ultrasonic decontamination) are employed on a case to case basis58,59. The efficacy of different
treatment methods is debated frequently, with their success remaining variable over long-term
studies60. One of the main reasons for this variability is the difficulty in managing PIM. The
continuation of PIM, as described above, leads to PI which is typically not responsive to nonsurgical interventions56,61,62. The failure to effectively treat infected dental implants and their
environment have led to increased rates of reinfection. While the risk of initial post-periodontal
infection is ~4%, the risk of reinfection or continued peri-implantitis 3-7 years after revision
treatments ranges from 16-25%63–65.

Due to the resistant nature of biofilms, IAIs have become one of the most common causes of
revisited surgeries and implant removal40,66,67. Efforts to mitigate the prevalence of biofilms on
implant surfaces have, to this point, showed mild effectiveness at eliminating the risks of postoperative infection. More specifically, the use of prophylactic antibiotic regimens has remained
minimally effective at targeting developed biofilms and fails to accommodate the continued risks
of infection throughout the lifetime of integrated implants. Therefore, the use of site-specific
antimicrobial action that can retard the formation of biofilms, or, provide a localized release of
biocidal components provides an attractive alternative in the treatment and mitigation of IAI.
2.1.2.2 Aseptic Loosening
While IAI remains the primary reason for the failure of most hard tissue implants, the loosening
of implants without the presence of microbial infection presents another clinically relevant issue.
Aseptic loosening is a result of the inability of an implant surface to bond to adjacent bone and
other tissues68. This lack of fixation leads to micromotions of the prosthesis which causes the
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formation of fibrous tissues arounds the implant, and subsequent loosening from the site of
implantation.
In the field of orthopedics, aseptic loosening is a major complication and is the cause of more
than 52% of hip arthroplasty revisions in the US annually69. Here, aseptic loosening typically
occurs following the release of particulate debris around the site of implantation. Particulate
debris can develop around the implant site from a variety of origins such as: poor surgical
technique, the loss of mechanically fixed bone cement, or wear at polymer-metal interfaces3,68.
The formation of wear debris leads to an elevated inflammatory response, bone resorption, and
osteolysis, leading to loosening and subsequent implant loss70. Unsurprisingly, aseptic failures
often require surgical revisions which include the complete removal and replacement of the
initial prosthesis with site re-debridement leading to significant losses in surrounding tissues.
Surgical revisions, in addition to increased hospital times for patients, carry increased risks for
additional failures following replacements. In a study following aseptic total knee arthroplasty
(TKA) revisions, 10% of revisions failed with majority of the causes being attributed to a
continued state of instability and IAI71.
Due to the lack of articulation between implant features and their decreased loads, the modes of
aseptic failure in the field of prosthodontics are not often attributed to the presence of particulate
debris. Instead, aseptic failures of dental implants are often attributed to poor bone quantity, poor
bone quality, and/or a lack of primary stability72. These factors can lead to excessive micro- and
macro-motion at the bone-implant interface which promotes the development of a fibrous tissue
membrane around the implant, subsequently leading to aseptic loosening and eventual failure73.
The absence of bone in these cases is often described by clinicians as marginal bone loss and is
frequently monitored throughout the lifetime of dental implants using radiographs. While this
method does allow for implant stability to be monitored over time, lack of patient compliance,
radiographic accuracy, and non-surgical interventions limit treatment efficacy73,74. Dental
implants that fail through aseptic modes are often replaced through the complete removal of the
initial implant, followed by either a 1 year wait period for the replacement of a similar screw
fixture, or, immediate replacement of a larger diameter screw fixture that removes the threading
and tissues surrounding the initial site72. In either case, these revisions in sites of aseptic failure
have show mild success with risks of failure up to 30%75,76.
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As with IAI, aseptic loosening remains a clinical concern where often invasive treatment
methods must be used at the burden of patient comfort and economic efficiency. Similarly, to
mitigate the potential for aseptic loosening events, surface systems that are targeted to improve
the fixation of hard tissue implants can afford a variety of advantages. Details of these systems,
as well as the interrelation of coating systems to target both complications will be highlighted in
the following sections of this literature review.
2.2 Implant Surface Modifications
Current strategies to mitigate the complications associated with IAI and aseptic loosening have
relied mainly on implant surface modifications. Although titanium possesses a robust and stable
film, its inert nature limits its ability to battle infections or promote long-term bonds with bone.
Herein, surface modifications to mitigate IAIs and aseptic loosening will be discussed.
2.2.1 Antibacterial Surfaces
As previously discussed, the treatment of IAIs and the formation of biofilms on implant surfaces
have shown minimal success and often present increased risks of continued infection. Given the
increased resistance of biofilms to systemic antibiotic regimens, surface modifications have
emerged as popular method to provide hard tissue implant materials with antibacterial properties.
Antibacterial surface treatments often act by preventing the primary adhesion of planktonic
bacteria to implant surfaces, or, by killing approaching bacteria. These two major approaches can
be summarized within non-eluting, eluting, and combination antibacterial strategies.
2.2.1.1 Non-Eluting/Static/Passive Antibacterial Strategies
Static antimicrobial surface modifications are currently one of the most common coating
strategies to target medical device related infections77. Such strategies are currently utilized in to
develop coatings for catheters, infusion lines, vascular stents and grafts, and sutures to prevent
biofilm formation and infection78. Many of the static antibacterial surface modifications
employed to date act either by preventing initial microbial adhesion (anti-adhesive action), or, by
killing microbes on contact with implant surfaces (contact-active action).
Anti-Adhesive Surfaces
Anti-adhesive or anti-fouling surface modifications passively target the initial adhesion of
planktonic bacteria to the surface of implant materials. Due to their passive nature, these surface
modifications are typically effective for long periods of time, leading to their popularity as
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coatings for a variety of medical devices. In the clinic, most of these coatings are currently
designed to be superhydrophobic to reduce bacterial adhesion and enable easy cleaning of
various medical instruments79. Typically, the chemical composition and roughness of material
surfaces are manipulated in conjunction to modify material wetting. In chemical modifications,
low surface energy materials, such as fluorinated compounds, are utilized to increase
hydrophobicity80. Once surfaces are hydrophobic, roughening in the micro and nano domain can
increase the hydrophobicity of materials further in a process described by Wenzel81. For titanium
materials, this process of roughening in conjunction with hydrophobic chemical treatments has
shown effectiveness against clinically relevant pathogens in a variety of studies. Tang et al. was
able to show a reduction in S. aureus colonization by roughening titanium surfaces with TiO2
nanotubes, followed by surface functionalization with a fluoroalkyl silane82. Privett et al.,
through similar methods, was able to show the reduction in S. aureus and P. aeruginosa adhesion
to roughened fluroalky silane coatings compared to untreated titanium surfaces83. This strategy,
while abundant in work, has seen little clinical translation for titanium and other hard tissue
implant materials. One reason for this lies in the differences between current commercial
applications of these coatings and their hard tissue target area.
Current applications of these coating technologies find greatest use as coatings for urinary
catheters lines84–86. These devices have a placement period of under 30 days and are not intended
to be integrated with host tissues, or, interface with protein-rich fluids such as blood and serum.
For hard tissue implants, materials directly interface with protein-rich physiological fluids and
nearly instantly develop a protein-rich conditioning film which dictates the foreign body
response to the implant87. This conditioning film may contain a wide range of proteins such as:
fibronectin, laminin, fibrin, collagen and immunoglobulins, which act as receptors to promote
surface colonization88,89. Potential colonizers of the conditioning film include tissue cells and
microorganisms which participate in a well established “race to (colonize)” the surface of the
material43. Through the colonization of a strong monolayer of tissue cells, the implant surface
can become resistant to colonization by microorganisms due to their viability, intact cell surface,
and regular host defences87. In contrast, the colonization of the surface by adherent microbes
leads to poor interactions with host tissue cells and potential implant failure. Anti-adhesive
coatings that employ superhydrophobicity limit the binding of host proteins. This in turn inhibits
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the adhesion of both bacterial and tissue cell adhesion, which leads to limitations for
osteogenesis and implant fixation90.
Given the importance of protein-tissue cell interactions for the successful fixation, integration
and biofilm prevention, mild and more specific anti-fouling coatings are currently under
investigation. Some of the most recent strategies in this area include pre-grafting specific ligands
and proteins to titanium implant materials to yield selective anti-fouling properties. An et al.
have shown that titanium implants materials grafted with bovine serum albumin (BSA) can
provide reduced rates of infection by S. epidermidis in rabbit models91. While this study utilized
albumin to specifically target the adhesion of host tissue cells, they did not directly assess its
interactions with osteoblasts. In another study an anti-fouling grafted PEG brush coating was
modified with the cell-adhesive arginine-glycine-aspartic acid (RGD) ligand to retain
interactions with osteoblasts92. In this study, the coating provided a reduction in the adhesion of
S. aureus to implant surfaces, while the RGD ligand-maintained interactions with osteoblasts.
Dextran, commonly used to decrease thrombosis, has also been used as a specific anti-fouling
coating material as it has been shown to provide specific tethering sites for bone stimulating
proteins such as bone morphogenetic protein 2 (BMP-2). A study by Shi et al., illustrated that the
adhesion of S. aureus and S. epidermidis can be reduced by 50% compared to control titanium
substrates93.
While mild and selective anti-fouling coatings have shown moderate success experimentally,
lack of tissue culture and in vivo data limits the consensus that they possess the features required
for bone implant usage. Other limitations include a lack of analysis relating to the fixation and
stability of selective antifouling coatings89,94. Despite the lack of clinically relevant data,
selective anti-adhesive surfaces present an interesting opportunity in the development of inert
implant surfaces to reduce the risk of IAI.
Contact-active Antimicrobial Surfaces
Similarly to anti-fouling surfaces, contact-active surfaces have the potential to provide medical
implants with antimicrobial properties without the release of biocidal agents. In contrast to antifouling surfaces, contact-active coatings often contain immobilized biocidal agents which are
designed to kill bacteria upon contact with implant surfaces. These immobilized biocidal agents
include components such as: antibacterial elements, antibiotics, and anti-microbial polymers and
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peptides. Most contact-active strategies currently employ some combination of these components
which have shown promising results.
The contact killing effects of antibacterial metallic elements has been known for hundreds of
years. Oligodynamic effects, or the biocidal effect of metallic elements, were formally
recognized in the late 19th century, although the usage of such techniques predates ancient
times95. Although the antibacterial effects of antimicrobial elements are well established, their
mode contact-killing action is widely debated. Until recently, their antibacterial action has been
mainly attributed to the release of metallic ions from bulk materials as a method to penetrate cell
membranes. This theory, however, has been proven to occur in conjunction with the direct
antimicrobial action of contact with metallic elements, where sophisticated protocols were
established to limit and monitor the release of metallic ions96,97. While the contact-killing action
of antimicrobial elements has not been fully elucidated, they have shown success in providing an
antibacterial effect in a variety of studies. Zeiger et al. showed that copper surfaces could be used
to successfully inhibit the growth of E. coli in a contact-based system to mitigate nosocomial
infections attribute to metallic devices98. More recently, Mauter et al. reported that grafting
polyethyleneimine-coated silver nanoparticles to the surface of polysulfone membranes can
provide excellent contact-active resistance to colonization of E. coli99. While metallic elements
are most prevalent in this research area, recent work has also investigated the use of non-metallic
antibacterial elements as well, such as selenium. Holinka et al. reported that selenium materials
have potential as orthopedic implant coatings as they provided reduced attachment of S. aureus
and S. epidermidis when compared to control titanium surfaces without affecting osteoblast
viability100.
Antibiotics and anti-microbial polymers and peptides function through damaging cell walls and
inhibiting protein synthesis in microbes101. Most of these active components are designed to be
contact-active through the use of polymeric spacers. These polymeric spacers are utilized to
allow grafted antimicrobial components to penetrate the cell wall of an adhered bacteria (Figure
2.5)102. Ketonis et al. utilized this strategy to covalently tether vancomycin to allograft bone
which showed significant reduction in S. aureus related surface colonization and stability over 60
days103. Given the emergence of antibiotic resistant strains of pathogens, such as methicillin
resistant S. aureus (MRSA), antimicrobial polymers and peptides have become significantly
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more popular as antimicrobial grafting agents. While antimicrobial polymers can be developed
synthetically with processes such as amine quarternization, emphasis has been placed on natural
antimicrobial polymers due to their inherent biocompatibility and decreased toxicity
concerns104,105. Chitosan, known to possess natural antimicrobial properties, has been extensively
studied as a natural polymer additive in contact-active antimicrobial systems. Chua et al.
reported that coatings consisting of polyelectrolyte multilayers of hyaluronic acid and chitosan
were significantly effective at reducing the adhesion of S. aureus on titanium implant
materials106. Cao et al. developed a modified chitosan surface which introduced N-halamine
structures that was effective at reducing the colonization of both S. aureus and E. coli compared
to control surface films107. Work with grafting antibacterial peptides has been met with similar
success. Kazemzadeh-Narbat at al. utilized a cationic antimicrobial peptide (AMP Tet213) in the
development of an antimicrobial calcium phosphate titanium implant coating108. The developed
coatings possessed antimicrobial activity against both Gram-positive S. aureus and Gramnegative Pseudomonas aeruginosa while providing a non-cytotoxic surface for osteoblast-like
cells. Similarly, Pfeufer et al, grafted a different cationic antimicrobial peptide (rHubD2) to
titanium implant surfaces using self-assembled siloxane monolayers109. Coatings developed in
this study possessed increased antibacterial efficacy against E. coli compared to titanium
controls.

Figure 2.5 Concept of contact-killing membrane-active biocides surface-coupled via a polymeric
spacer. Adapted from Börner et al.102
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While work on developing novel contact-active antimicrobial coating systems is emerging, there
is still a high degree of skepticism with their possible translation as coatings for titanium implant
materials. Similar to anti-adhesive coating systems, contact-active systems have shown little
evidence of success in tissue culture and in vivo studies. This leads to a lack of conclusions
related to the cytotoxicity, immunoreactivity, and genotoxicity of developed coatings in
orthopedic and dental implant systems. In the case of contact-based coating solutions using
antimicrobial elements, the release of toxic ions from coating matrices presents a relevant
cytotoxic concern110–112. In the case of coatings based on grafting antimicrobial polymers and
peptides, the sensitivity and robustness of covalent coupling over time presents another clinically
relevant toxicity issue113. Finally, while repelling and killing microbes on contact are obviously
advantageous in an antimicrobial system, they can be easily deactivated through their contact
with physiological fluids. Non-specific fouling of these surfaces can occur from dead cells and
other physiological contaminants which deactivates these antibacterial systems and can allow
microbes to colonize. In these cases, only systems that employ the release of biocides can retain
their activity.
2.2.1.2 Elution-based/Active Antibacterial Strategies
Elution-based antibacterial strategies rely on the release of biocidal components to form a
bacterial inhibition zone around the implant surface. The formation of this inhibition zone,
attributed to the flux of biocides from eluting coating materials, has been shown to both reduce
surface colonization in vitro and prevent the formation of biofilms in vivo114. Additionally, the
elution from coating materials at the site of implantation enables the delivery of high local doses
of biocidal components without exceeding systemic toxicity levels115. Since dead microbial cells
cannot actively adhere to the substrate, they typically do not cover and deactivate the releasing
coating material at high densities. Eluting coating systems may contain a single or combination
of biocides such as: antibiotics, silver compounds, quaternary ammonium compounds (QACs),
and nitric oxide. Many elution-based antibacterial coating systems rely on either a diffusioncontrolled or a dissolution-controlled release method. These release methods can be further tuned
to respond to certain biological cues, making the release of biocides stimuli responsive. Such
triggered systems prevent the premature exhaustion of loaded biocidal components and mitigates
the diminution of release the occurs in constant release systems102. In the area of antibacterial
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coatings, each strategy affords different advantages and disadvantages in the localized delivery
of biocides.
Diffusion-Controlled Coating Systems
Diffusion-controlled coating systems are non-erodible in physiological fluids and employ the
delivery of biocides through reservoir or matrix delivery strategies. In a reservoir delivery
system, biocides are dissolved or dispersed in a reservoir that is surrounded by a rate limiting,
non-erodible membrane116. The release of biocides from the reservoirs of these systems are
determined by their permeability and diffusion through a non-erodible membrane. In matrix
delivery systems, biocides are dissolved or dispersed within the coating matrix without the
presence of a rate controlling membrane. The release of biocides from these systems are
determined by the concentration of biocide remaining within the permeable coating matrix. Both
reservoir and matrix loading strategies have represented a large portion of work on antimicrobial
implant coatings with a particular focus on the field of orthopedics.
Using a reservoir-loading strategy, Vasilev et al. incorporated the antibiotic lefofloxacin between
two non-erodible polymer layers117. They found that the release of lefofloxacin could be
effectively controlled by modifying the thickness of the outermost polymer layer, leading to a
reduction of S. aureus colonization on implant materials. Other reservoir delivery strategies have
involved the loading of biocides within porous reservoirs followed by the application of a nonerodible polymer coating membrane to control release. Michl et al. utilized this strategy to
deliver nitric oxide from a porous reservoir in a controlled fashion to reduce the colonization of
S. epidermidis on biomedical implant surfaces118. Kumeria et al., using a similar strategy, loaded
titanium nanotubes with gentamicin and utilized a polylactic-co-glycolic acid film to control
release119. Using this reservoir-release strategy the colonization of S. epidermidis was reduced
while maintaining adequate osteoblast adhesion.
The most common use of matrix-bound biocide delivery systems has been in the field of
orthopedics. Here, the use of vancomycin and gentamicin imbedded within non-erodible
poly(methyl methacrylate) (PMMA) cement beads and coating materials has become a standard
feature of two-stage revisions50. The use of such materials has been shown to lower the rates of
postoperative infections by 8-12% compared to the use of traditional systemic antibiotics120,121.
More recent studies have investigated the use of similar delivery methods using different matrix
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materials. Kumar and Munstedt used a non-erodible polyamide coating material loaded with
silver to provide an effective release of silver ions, which prevented the colonization of E coli
and S. Aureus on hard material surfaces122. Thatiparti et al., utilized a swelling cyclodextrinbased coating matrix on titanium substrates to release vancomycin123. These coatings were able
to inhibit the growth of S. aureus for over 28 days and retained osteoblast cytocompatibility.
While diffusion-controlled systems have shown favourable results, there are significant
limitations to their adoption as coating materials for orthopedic and dental implants. In nonerodible coating systems, the matrix or release-limiting membrane is often a non-biodegradable
polymer material. This poses questions as the long-term robustness and retention of these
membrane and matrix materials as well as their ability to promote the colonization of healthy
tissues. Additionally, the release of biocides in diffusion-controlled antibacterial coatings
diminishes with time until the quantities delivered loose efficacy and become subinhibitory88.
The release of subinhibitory concentrations of biocides over time not only limits the long-term
effectiveness of these coating materials, but also leads to the development of biocide-resistant
pathogens124.
Dissolution-Controlled Coating Systems
Similar to diffusion controlled antibacterial coating systems, dissolution-controlled systems
enable the continuous release of imbedded biocidal components. In contrast to diffusioncontrolled systems, dissolution-based coating systems have release kinetics determined by the
dissolution or erosion of their coating matrices in surrounding fluids. In these systems the release
of imbedded biocides can be modified by changing the rate at which the coating matrix dissolves
or erodes in the selected dissolution media. For this reason, the use of a variety of biodegradable
organic and inorganic matrices have been explored as methods to develop antibacterial coatings
that release biocides in the presence of physiological fluids. In the field of orthopedics, the
controlled delivery of antibiotics based on these biodegradable or erodible coating matrices has
become a popular area of research since the standardization of cementless prostheses125.
Such systems have been developed using matrices composed of a variety of organic networks
such as polylactic-co-glycolic acid copolymers (PLGA)126,127 and poly(D,L-lac- tide)
(PDLLA)128–130 as well as inorganic networks derived from sol-gel precursors131,132. For
example, Kim et al. utilized a biodegradable PLA coating network loaded with chlorhexidine to
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improve the antibacterial efficacy of dental implant materials133. Through the degradation of the
PLA coating network and release of chlorohexidine, the developed coating materials were able to
effectively reduce the viability of S. aureus in culture. In a similar study, Metsemakers et al.
developed a biodegradable PLGA coating matrix loaded with doxycycline to mitigate implant
associate infection134. This coating material provided protection for titanium alloy implant
materials against clinically relevant methicillin-resistant S. aureus (MRSA) in a rabbit model. As
for inorganic systems, sol-gel materials show significant promise in their applications within
orthopedic and prosthodontic domains. Typically composed of siloxane networks, developed solgel films have notoriously high substrate adherence and possess natural osteoconductive
dissolution products 135,136. In pioneering studies, Ducheyne et al. utilized this feature of siloxane
networks to develop vancomycin loaded xerogel coatings to effectively inhibit the colonization
of S. aureus on a variety of titanium implant materials131,137–139. Other sol-gel based coating
networks have been loaded with silver compounds140–142, quaternary ammonium
compounds143,144, and nitric oxide145,146 that have shown great robustness and effectiveness again
clinically relevant pathogenic bacteria such as E. coli, S. aureus, S. Epidermidis, and S. mutans.
While dissolution-based coating strategies certainly illustrate great potential for hard tissue
implants, there are still some significant limitations to their adoption in the clinic. These erodible
coating systems, especially those made of biodegradable polymers, have similar concerns related
to their longevity and robustness within host tissues. Similar to diffusion-based systems, the
release of biocides from the coating materials diminishes with time leads to the possibility of
developing of biocide-resistant pathogens124. However, unlike diffusion-based systems the
release kinetics associated with degradation in dissolution-based systems are often difficult to
control, with some coatings only providing an initial burst release of biocides during the first few
hours of contact with physiologic fluids89,124.
Stimuli-Responsive Systems
Materials that respond to external stimuli have been investigated in the biomedical field for
decades with applications as biomedical sensors, actuators, and coating materials124. In the
development of elution-based coatings, these systems can eliminate some of the major
limitations to the designs of both diffusion and dissolution coating systems. Unlike the later
systems which liberate and exhaust their imbedded biocides quickly and continuously, stimuli21

responsive eluting coatings release imbedded biocides only in response to specific stimuli.
Stimuli-responsive antibacterial coatings can rely on either the triggered degradation or swelling
of the coating matrix to achieve controlled elution of imbedded biocides. The elution of biocides
in both cases can be triggered by both physiological and exogenous stimuli.
Most stimuli-responsive antibacterial coating systems rely on biological triggers from
surrounding bacteria. Through their metabolic cycle, bacteria produce a range of acidic
substances, such as lactic and acetic acid, which lead to a pH drop in their immediate
environment147. For this reason, several antibacterial coating systems that respond to changes in
pH have been investigated. Using a nano-valve reservoir equipped with a pH responsive
membrane, Wang et al. successfully achieved the release of cinnamaldehyde and ampicillin in
the presence of pathogenic bacteria148. These coating materials provided a trigger active defence
against S. aureus, E. coli, and MRSA. In another study, Zhuk et al. combined cationic
gentamicin, tobramycin and polymyxin B, with polyanionic tannic acid in the development of
antibacterial polyelectrolyte multilayer films149. These films, responsive to changes in pH,
strongly inhibited the growth of S. epidermidis and E. coli on surfaces and in surrounding media
while maintaining osteoblast adhesion and viability. The pH change in the presence of bacteria
can also be used to liberate grafted biocides in coating materials. Using this strategy, gentamicin
was grafted to a PEO nanoparticle coating using pH-sensitive imine bonds150. Coated titanium
materials showed selected release at lower pH ranges and inhibited the growth of S. aureus.
While stimuli from bacteria are most often utilized to activate these systems, other biological
triggers which result from infection can also be used. For example, in the case of wound
infections, the on-site production of the enzyme thrombin increases dramatically151. Using this
trigger, Tanihara et al. developed a coating material consisting of crosslinked PVA with a
thrombin-degradable crosslinker152. This coating material effectively released gentamicin only in
the presence of thrombin, which actively inhibited the growth of S. aureus and P. aeruginosa
bacteria.
Similar to biological stimuli, use of externally applied exogenous stimuli can afford a high
degree of control over the release of biocidal components from stimuli-responsive coatings.
Unlike biologically responsive coatings, exogenous stimuli can be applied in a prophylactic
fashion, that may protect implant surfaces in the early stages of the “race to the surface” before
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measurable chemical changes occur. Responsive coating materials can be triggered to release
biocides from electrical, ultrasonic, photothermal, magnetic, and mechanical triggers153. For
example, Esrafilzadeh et al. utilized an electropolymerized polypyrrole coating to allow the
electrically controlled release of cipropfloxacin154. Coated conductive fibers were non-cytotoxic
and displayed significant inhibition of both S. pyogenes and E. coli growth under electrical
stimulus. In another system, Norris et al. developed a poly(2-hydroxyethyl methacrylate)
hydrogel coating with ordered methylene chains as an ultrasound-responsive coating for
indwelling protheses155. This system was able to retain loaded ciprofloxacin in the absence of
ultrasound, and, provide controlled-release in the presence of low-intensity ultrasound.
Triggered-release doses from this developed coating system provided significant inhibition to the
growth of P. aeruginosa on material surfaces. Using a magnetic field, Aw et al. presented a
coating system that can be used to release active drug components from a titanium nanotube
reservoir upon application of magnetic stimulation156. In this work titanium implant materials
equipped with titanium nanotubes were loaded with drug-encapsulated micelles and were
released only under the presence of magnetic stimuli. While this work did not explicitly use the
release of biocides or preform experiments with bacterial cultures, the encapsulation of
antibiotics in such a system is promising in this area.
While stimuli-responsive antibacterial systems provide “on-demand” therapeutic effects, there
exist some limitations to their adoption in the clinic. For starters, there is a high degree of
skepticism about how sensitive these systems are to their triggered stimuli in vivo. Given the
dynamic nature of the body, systems that may promote release of biocides to changes in pH may
not be suitably sensitive. Local pH changes associated the early stages of infection can be quite
small are difficult to predict in vivo. Such pH changes can depend on the presence of different
species of bacteria, the bacteria state (planktonic or biofilm) and the size and location of the
implant. For this reason, many systems relying on release from biological stimuli may provide an
effect too late as infections have been shown to occur as early as early as six hours of postoperatively from small quantities of pathogenic bacteria114. For systems that rely on external
stimuli to release biocides, their application may be limited as they require the pre-identification
of infection before their application. For this reason, their applications may be inappropriate in
conditions where there is a sudden onset of inflammation or viral attack. This strategy is also
significantly limited by patient compliance and access to the clinic.
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2.2.2 Osteoconductive Surfaces
In the founding study by Brånemark, osseointegration was described as the direct anchorage of
an implant material by the formation of bony tissue around the implant157. Since then, many
alternative definitions have been proposed to better describe the details of this phenomenon.
More recent definitions identify osseointegration as a foreign body response, one in which
interfacial bone may be formed as a defence to shield surrounding tissues from implant
materials158. Nevertheless, this integration originally identified by Brånemark remains a
fundamental factor in promoting the bony attachment and fixation of hard tissue implant
materials. A wonderful review by Albrektsson and Johansson breaks down the two major factors
influencing osseointegration: osteoinduction and osteoconduction159.
Osteoinduction describes the stimulation or promotion of undifferentiated pluripotent cells to
differentiate into those within the bone-forming or pre-osteoblast cell lineage158. This process
occurs naturally in bone fracture healing and implant incorporation. In a traditional healing
process, sensitized surviving cells release local biochemical and biophysical cues that help
promote the differentiation of pre-osteoblast cells160. BMP, a soluble bone growth factor known
to be naturally released in response to bone trauma or remodeling, has been identified as one of
the only known naturally inductive agents. Although the recruitment of pre-osteoblast cells is
typically unobservable for several weeks, the process of osteoinduction begins immediately
following implantation, making it a fundamental factor in the “race to the surface”.
Osteoconduction describes the action of differentiated bone cells to promote bone tissue growth
around foreign surfaces. This process includes the release of growth factors which serve as
signaling agents for bone cells in the production of bony tissues. In many ways the process of
osteoconduction depends on the process of osteoinduction. Unlike osteoinduction,
osteoconduction is strongly dependent on the biomaterial used for implantation. For this reason,
materials, topographical cues, and eluting agents are most frequently investigated to optimize
osteoconduction since the injury at placement is often sufficient to recruit the differentiation of
pluripotent cells.
While initial osseointegration may be achieved through the strong osteoinductive and
osteoconductive cues, the long-term stability and retained osseointegration remains a relevant
issue. For this reason, surface strategies concerning the promotion tissue ingrowth and long-term
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stability of hard tissue implants (osteoconduction and osseointegration) have been of primary
focus of researchers. Many of such strategies promote these factors using topographical cues or
bioactive coatings to ensure long term fixation of implant materials and prevent aseptic
loosening.
2.2.2.1 Topographical Strategies / Bioactive Topographies
Surface topographies are important factors that influence the bioactivity of all biomaterials.
Indeed, the effect of surface micro- and nanostructures are well established to determine cellular
behaviors such as adhesion, proliferation and differentiation161. For this reason, altered
topographies can influence osteoinduction, osteoconduction and, accordingly, improve
osseointegration. To improve the bioactivity and osseointegration of titanium implant materials a
variety of surface topographies have been developed that mimic the cellular microenvironment.
Such surface strategies can be further separated into micro- and nanostructure templating which
impart their own spatiotemporal cues to cells in vivo.
Surfaces roughened in the micro-domain are used to promote osteoblast adhesion, differentiation
and to provide an appropriate surface for the mineralization of extracellular matricies162.
Through the addition of a micro-pattern to Ti6Al4V substates, Lu et al. was able to show
increased apatite induction in vitro and increased bone growth and proliferation in vivo163. In
another study, Liao et al. investigated the role of surface microtopography on bone cell
differentiation164. Using a micro-pyramid design, they observed an increased differentiation of
rat calvaria osteoblasts compared to smooth surfaces in vitro. Similarly, surfaces with nanotopographies have been used to promote implant fixation. These structures are more similar
natural physiological orientation of native bone and play an important role in bone cell adhesion
and integration165. Many of the nanostructures developed on titanium surfaces are titania
nanotubes due to their ease of tunability using traditional anodizing techniques166. Nune et al.
used this strategy of anodizing Ti6Al4V to develop surface titania nanotubes with a pore size of
~80 nm167. Their structures promoted the nucleation of apatite globules in vitro and improved the
proliferation and adhesion of mouse pre-osteoblast cells in culture. In another study, Wang et al.
developed titanium implants with 70 nm titania nanotubes168. Following a five-week
implantation period in a pig model, nanotextured implant surfaces displayed increased boneimplant contact and osseointegration compared to control titanium surfaces. Brammer et al.,
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using a smaller titania nanotube size (30 nm), also demonstrated increased osteoblast adhesion
compared to control titanium surfaces in culture169.
In general, topographical manipulation provides relatively simple and stable enhancement to the
bioactivity of hard tissue implant surfaces. Addionally, the technologies to develop such
topographies (anodizing, plasma spraying, acid-etching) are scalable, making them feasible as
commercial solutions166. There are, however, major limitations to these strategies being used
solely as implant surface materials. By developing surfaces that promote cell adhesion and
proliferation, there is often an added increase to the adhesion and proliferation of microbes.
Studies have shown that some nanotopographies, such as nanotublar and nanotextured titanium,
while providing a favourable environment for osteoblasts, indeed increase the adhesion of
microbes to implant surfaces170,171. For this reason, the implementation of such topographies may
provide more of a risk to the success of intraosseous implants despite their promotion of
osteoinductive and osteoconductive cues. Accordingly, other studies have investigated the use of
such topographies in conjunction with bioactive coating materials to provide a more “cell
tailored” surface.
2.2.2.2 Bioactive Coatings
While topographical roughening typically provides a non-specific influence on adhesion and
proliferation, the effect of bioactive coating materials is often more specific to influencing bony
ingrowth. Due to the release of naturally osteoconductive ions from these materials (such as Ca,
P, Si, and Mg), they have the ability to stimulate osseointegration without providing factors to
influence the adhesion or proliferation of microbes172. A wide range of such bioactive materials
have been investigated for use as orthopedic and dental implants coatings. These include
traditional calcium phosphate or hydroxyapatite coatings, bioactive glass coatings, and newly
emerging bioactive hybrid coatings.
Hydroxyapatite-based Coatings
Calcium phosphates, and more specifically, hydroxyapatite (HA) coatings were among the first
to be proposed to replace traditional cemented fixation of prothesis173. HA-based materials were
identified as promising biomaterials due to their similar chemical and crystalline structure to the
inorganic phase of human bone. The emergence of HA coatings in the clinic was further spurred
by their early display of significant improvements to the fixation and lifetime of metallic
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implants174. This has been identified to occur due the formation of a carbonated-HA layer on the
surface of HA coated materials shortly after implantation in vivo. This structure results from the
elution of calcium and phosphate ions from HA coating materials which induces the deposition
of relevant physiological proteins and provides an appropriate scaffold for osteoblasts in the
formation of new bony tissue174. Research in HA-based implant coatings spans decades and has
been the study of many clinical trials175–178. For this reason, to date, HA-based plasma sprayed
coatings remain the only orthopedic implant coating material approved by the FDA179.
Despite thorough investigations into these materials, their clinical success and predictability
remains controversial. Indeed, the integration of these materials in vivo compared to bare or
textured titanium surfaces have been proven to be marginal, or in some cases, less effective180–
183

. Such studies have helped to better elucidate the shortcomings of plasma sprayed HA-based

coatings which include phase inconsistency, coverage and topographical concerns, and coating
delamination.
During the high temperature plasma spraying application of HA coatings to metallic substrates,
HA can undergo phase changes, which in general, affect the crystallinity of the coating material.
Such secondary phases include tricalcium phosphate, calcium oxide (CaO), tetracalcium
phosphate (TTCP) along with amorphous calcium phosphate (ACP)184,185. Difficulties exist in
consistently controlling these phases within the processing conditions of plasma spraying which
can greatly affect the bioactivity (or lack thereof) of plasma sprayed HA-based coatings.
Additionally, plasma spraying is a line-of-site technique which limits its ability to accommodate
the fine contours or geometric complexities of some implant materials. This can lead to
inconsistent coating thickness and heating of implant materials, affecting not only the phase of
the coating material but also that of the metallic substrate179. Along with an inability to
accommodate fine geometries, the coating application of HA-based materials are often quite
thick and dense leading to the coatings inability to match the topography of pretreated surfaces.
Such surfaces are unable to provide the relevant topographical cues attributed to substrate pretreatments (previously discussed) to improve the growth and proliferation of osteoblasts.
Lastly, and perhaps most importantly, some studies have addressed the potential for HA-based
coatings to undergo delamination in vivo174,186,187. As previously discussed, the delamination of
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coating materials leads to the production of debris and micromotion of prosthesis, which can
ultimately result in aseptic loosening.
Other coating methods that utilize sol-gel liquid techniques have been developed to aid in the
control of HA coating properties188. Despite their low temperature application, such coatings
need to be cured at high temperatures to produce crystalline HA189,190. Through this calcination
process secondary phases of HA are developed, which leads to inconsistent dissolution
properties and, due to differences between the thermal expansion coefficients of the coating and
substrate, often cracking.
Although plasma sprayed HA-based coatings are the current standard and only FDA approved
orthopedic and dental implant coating materials, there is a need for alternative materials that
overcome their shortcomings. While the proposed bioactive conduction method through the
release of osteoconductive ions remains a viable bioactive model, the lack of consistency in their
material properties limit the application of these coatings in the clinic. Therefore, further studies
have investigated coating materials with improved material properties while possessing similar
osteoconductive strategies.
Bioactive Glass Coatings
Bioactive glasses consist of a variety of glass-ceramic materials (typically silicate based) that
promote the bonding and mineralization of bone tissue. The first bioactive glass named
“Bioglass” was invented by Larry Hench in 1969 and consisted of 46.1 mol.% SiO2, 24.4 mol.%
Na2O, 26.9 mol.% CaO and 2.6 mol.% P2O5. The original Hench Bioglass has since been used in
over a million patients in the repair of bone defects during oral and orthopedic surgeries191,192.
Such glasses can be synthesized using a traditional melt-quench methods or sol-gel techniques.
Sol-gel derived bioactive glasses display higher surface areas, rates of bioactive ion release, HA
formation and crystallinity compared to melt-derived glasses, and have thus been more
frequently studied193. Almost all synthesized bioactive glass materials contain Si and Ca species
as these ions in specific concentrations are known to elicit positive bioactive responses such as
the promotion of new bone tissue growth191. An excellent review by Jones delves in great detail
into various bioactive glass compositions and their uses as bone-growth grafting materials192. As
Jones highlights in his review, despite their ability to promote rapid bone growth, these materials
pose some complications for applications as implant coatings.
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Most feasible bioactive glass coatings are synthesized using the sol-gel technique. Sol-gel
systems, briefly touched on in Chapter 2.2.1.2.2, are prepared through the hydrolysis and
condensation of liquid ceramic precursors. Since sol-gel materials typically have higher surface
areas and porosities compared to traditional melt-quench glasses, they often better promote cell
adhesion and tissue ingrowth as coatings194. Using a sol-gel synthesis, Köseoglu et al. developed
a HA and bioactive glass dual coating for use on metallic implants195. Their HA/bioactive glass
coating material displayed significantly more apatite deposition during in vitro testing than HA
coating materials. In another study, Hamadouche et al. used a sol-gel derived Bioglass
formulation to coat alumina implants196. These coatings increased the deposition of HA on
implant surfaces in vitro and eliminated aluminum leaching compared to uncoated controls. Both
of these coatings, however required the use of high curing temperatures (>600°C) to enable the
inclusion of calcium into the coating network. This led to significant cracking and fissures of the
inorganic coating materials, leaving in question their robustness and longevity of these coatings
in vivo.
When form is of no concern, such in the case of powder development, processing bioactive
glasses at high temperatures remains ideal from a processing perspective. For materials that
assume the form of a mold or template, as in the case with scaffolds and coatings, developed
materials are often too brittle to provide adequate support, or, crack and delaminate upon curing
on metallic substrates. For implant coatings, this leads to many of the same issues associated
with the sol-gel processing of HA-based materials, also prone to material separation and
significant coating cracking. The reason for such cracking can be attributed to the large
shrinkage that occurs during drying and the evaporation of the liquid by-products of the sol-gel
synthesis192. Unlike HA-processing where crystallinity is the main objective, high temperatures
for bioactive glass processing are used to ensure that all liquid components are included into the
coating network. For example, it is common for bioactive glasses to include Ca into the coating
network using sols containing CaNO3 or CaCl2197. For Ca to be included into the cured network
and to remove the potentially toxic salt by-products, these materials must be annealed at >400°C.
This process is not always ideal, and often, due to the salts solubility in the pore liquor of the sol,
can lead to an inhomogeneous surfaces distribution of elements198.
.
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Hybrid Material Coatings
To improve upon the mechanical properties and processability of bioactive glasses for use as
coatings, several composite and hybrid systems have been developed to combine organic
polymers with sol-gel ceramic materials. Through the simple blending of these organic and
inorganic networks, sol-gel composite materials can be developed. This method, however,
usually leads to inhomogeneous materials with mismatching degradation rates, which can cause
instability and premature deterioration of composite materials 192,199. Alternatively, hybrid
material systems, possessing nanoscale molecular interactions between the organic and inorganic
phases, have shown significant improvements in stability over their composite counterparts.
These hybrid materials are further characterized based on the molecular interactions between
their organic and inorganic components. When weak molecular interactions (such as hydrogen
and van der Waals bonding) are present between organic and inorganic components they are
designated as class I hybrids. In the case where strong covalent interactions are present between
both organic and inorganic components materials are deemed as class II hybrids. Highlighted
below are examples of promising class I and class II hybrid materials for use as implant coatings
as well as a discussion on integration of calcium.
Using class I hybrid materials, a variety of researchers have been able to improve the bioactivity
of implant surfaces. For example, Catauro et al. has investigated the use of poly (ɛ-caprolactone)
(PCL) and polyethylene glycol (PEG) to develop class I siloxane hybrid coatings200–202. These
coatings, when applied to Ti substrates, displayed superior bioactivity by promoting the vitality
of mouse embryonic fibroblast cells compared to bare Ti substrates while displaying crack-free
coatings with good adhesion properties. Other studies have investigated using natural polymers
such as chitosan and gelatin as the organic components in their class I hybrids. Pebdeni et al.
developed a nanofiber coating for use on orthopedic implants that consisted of chitosan, PEO,
and silica203. Chitosan, in this study, acted to improve the flexibility of the developed nanofibers
and increase the attachment and growth of fibroblasts. In another study, Jun et al. used chitosan
to improve the material properties of a bioactive sol-gel coating composed of
tetramethylorthosilane (TMOS), CaCl2 and triethyl phosphate204. Hybrid coating materials were
crack-free compared to their inorganic counterparts and displayed appropriate levels of cell
attachment, bone forming ability, and mineralization.
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Compared to the simple entanglement of organic and inorganic chains, class II hybrids act as
single-phase materials exhibiting improved mechanical properties and material homogeneity
compared to class I hybrids. This is particularly the case with dissolution characteristics of
hybrid materials. Due to the lack of covalent coupling present between the two phases in class I
hybrids, organic components can often be lost more rapidly than inorganic components in
dissolution studies. This emphasizes the fact that class II hybrids may be more suitable for
implant coatings where material properties, including degradation and dissolution rates, are often
congruent throughout the material.
Class II hybrid materials has become an increasingly popular research area in the development of
hard tissue implant coatings. Studies have investigated the use of a variety of organic, coupling,
and inorganic agents in the development of these coatings. Many relevant studies have
investigated class II systems consisting of chitosan as an organic component, coupled to
inorganic siloxane networks using 3-glycydoxytrimethoxysilane (GPTMS). For example, PallaRubio et al. used such a system as a coating for Ti implant materials that facilitated the release of
osteoconductive Si which promoted the proliferation of human fibroblasts in culture205. In other
studies, Shirosaki et al. showed how these coating materials could also promote the adhesion and
proliferation of an osteoblastic cell line (MG63) compared to relevant controls and remain stable
for up to 6 months in enzymatic solutions206,207. Other materials have been developed using
similar systems but with varying organic networks components such as gelatin, poly(γ-glutamic
acid), and PEG208–210.
These materials, owed to their low temperature processing, have also been able to manifest
antimicrobial properties. For example, the coating materials involving chitosan above were able
to provide a degree of antimicrobial efficacy against relevant pathogenic bacteria while
providing a crack-free surface204,205. Other examples include the work of Pebdeni et al. and
Hernández-Escolano et al. where they used the low temperature synthesis of the hybrid coating
materials to enable the loading of temperature-sensitive antimicrobial agents cefepime and
procaine, respectively203,211. These materials provided a significant antimicrobial effect along
with displayed signs of bioactivity. The multifunctional nature of these materials has become
particularly attractive to researchers as coatings that can promote osseointegration whilst
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mitigating microbial proliferation can effectively eliminate both major failure modes effecting
implantology today.
Most of the above-mentioned class II hybrid materials, and those reported in literature, consist of
a polymer-siloxane system. The synthesis and integration of calcium into such materials remains
challenging due to their low temperature synthesis and curing temperatures192. For this reason,
more recently, calcium alkoxides have been investigated as precursors to incorporate calcium
into the inorganic portion of sol-gel hybrid materials. These precursors participate in the same
network forming hydrolysis and condensation reactions as traditional silica precursors, allowing
their simple integration into these networks at room temperature
Accordingly, more advanced methods in the development of multifunctional hybrid coatings
have utilized calcium alkoxides to allow low temperature Ca integration into sol-gel networks.
For example, Li et al. developed PEG/SiO2-CaO class II hybrid coating materials using calcium
methoxyethoxide (CME)212. Hybrid materials developed in this study possessed a degradationcontrolled release of calcium and promoted apatite deposition on all material monoliths Coating
materials were able to be cured at low temperatures and displayed enhanced apatite deposition
while exhibiting good cell viability and proliferation. In another study, Poologasundarampillai et
al. developed Poly(γ-glutamic acid)/SiO2-CaO hybrids using the same CME precursor213. Most
of the calcium alkoxides used to date, however, have had a high sensitivity towards hydrolysis
and condensation reactions in the presence of water. This instability in aqueous systems often
leads to premature gelation of the inorganic network leading to poor and inhomogeneous
integration of calcium into hybrid materials. Additionally, many of these calcium alkoxides, if
not hydrolyzed completely, can leach toxic by-products in vivo (such as methanol for calcium
methoxide and calcium methoxyethoxide).
Therefore, while bioactive class II hybrid materials present desirable characteristics, there is a
need to improve their properties for use as hard tissue implant coatings. In an effort to better
assess their potential to be clinically translatable, more rigorous delamination initiatives should
be pursued to assess the adhesive properties of these coatings. Additionally, due to their low
temperature synthesis, antimicrobial agents should be opportunistically added to material
coatings to provide implant materials with an effective resistance against pathogenic bacteria.
And lastly, there is a need to investigate new calcium alkoxide precursors that possesses less
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toxic degradation products and increased resistance to water to enable the inclusion of calcium
into coating networks at low temperatures. The above points will be the focus of the work
presented in this thesis.
2.3 Rationale of the Study
Titanium implant materials, while ideal from a biomechanical standpoint, are plagued clinically
by two major complications: IAI and aseptic loosening. While these issues seem distinct given
their nomenclature, their interrelation and the “race to the surface” between native cells and
pathogens is often attributed to the success or failure of implants in both domains43. Various
antimicrobial coating strategies have been developed to target a range of pathogenic bacteria
which each afford their own advantages and disadvantages. Osteoconduction on the other hand,
has been well established to be promoted by topographical stimuli and the dissolution of relevant
inorganic ceramic materials. Both coating strategies, in addition to their relevant cues, need to be
resistant fracture and delamination to be feasibly implemented in the clinic.
Therefore, the purpose of this study is to develop multifunctional coating materials that can:
1. Manifest antimicrobial properties that can be applied in a complementary manner
(contact and release based)
2. Provide inherently osteoconductive/bioactive physiological cues
a. Through the use of hybrid bioactive glass networks
b. Using a new calcium alkoxide precursor
3. Possess a degree of mechanical robustness to promote clinical translatability
With this in mind, this study describes the synthesis of robust class II hybrid multifunctional
coatings to improve success of titanium implant materials.
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Chapter 3: Development of robust chitosan–silica class II hybrid coatings
with antimicrobial properties for titanium implants*
3.1 Introduction
Titanium and its alloys have been the material of choice for biomedical implants over the past
half century. Their low specific weight, high strength to weight ratio and resistance to corrosion
are features that make titanium the ideal bulk material for numerous clinical applications1. These
include orthopedic and dental implants where their resistance to chipping and capacity to endure
repetitive high loading conditions are an advantage over non-metallic substrates. Furthermore,
the titanium dioxide layer that forms on their surfaces is highly inert and biocompatible to the
cells and extracellular matrix of surrounding tissues.
However, the bio-inertia of titanium surfaces is accompanied by a lack of any significant
antimicrobial properties. While implanted titanium materials are well received by the osseous
and connective tissues of their host, microbial contamination of their surfaces and the surgical
site can often lead to sustained infections and unfavorable patient outcomes. These implantassociated infections are currently a major cause of orthopedic and dental implant failures. Postoperative infections associated with biomaterial implantation range from 2%–5% for orthopedic
procedures and 4%–11.5% for dental and oral surgeries2–4. These infections are often extremely
resistant to systemic antibiotics and persist until the implant has been surgically retrieved.
The persistence of implant-associated infections is likely due to the presence of polymicrobial
biofilms that have formed on implant surfaces. These biofilms contain bacteria that are encased
within a bacterial-excreted polysaccharide matrix, which is highly adherent to biomaterial
surfaces and largely resistant to the external environment. Accordingly, the bacteria within
biofilms may be up to 1000 times more resistant to antibiotics than bacteria that are suspended in
a planktonic state3,5.
Therefore, research has now been directed toward the modification of implant surfaces to prevent
initial bacterial adhesion and subsequent biofilm formation. Most antimicrobial strategies have
relied on either static antimicrobial activity from direct or indirect surface modifications or they

*

A version of this chapter has been published: Z. Gouveia, H. Perinpanayagam, J. Zhu, Coatings 2020, 10, 1–20

49

have implemented release-based antimicrobial action using biocides imbedded within material
surfaces.
Static antimicrobial strategies involve modifications to implant surface properties which can alter
their surface roughness, hydrophilicity and/or surface functional groups6–8. Therefore, such
intensive surface modifications can lack selectivity for biomedical applications and may
inadvertently reduce favorable surface interactions with mammalian cells. These cellular
responses are necessary for cell attachment and adequate osseointegration with surrounding
tissues9. Furthermore, while static antimicrobial factors may inhibit or retard initial bacterial
adhesion and proliferation, they become ineffective once biofilms become established on
biomaterial surfaces.
In contrast, release-based antimicrobial strategies typically employ a coating system that enables
the release of biocidal components such as antibiotics, cationic molecules or metallic
compounds10–13. Systems that employ release-based antimicrobial strategies often involve an
initial burst release of the imbedded biocidal agents that have short-term effects, which are
followed by a subsequent diminution of activity. Additionally, for release-based systems the
choice of an antibiotic as a biocidal agent may be contraindicated by the rise in antibioticresistant infections from resistant bacterial strains14.
Therefore, recent interest has focused on the utilization of metallic nanoparticles as antimicrobial
agents, due to their broad-spectrum effects15,16. Among these, silver nanoparticles (AgNPs) have
garnered significant interest due to their limited cytotoxicity, ease of synthesis, low minimum
inhibitory concentrations for many pathogenic bacteria and their antimicrobial efficacies in both
static and release-based applications17–19. AgNPs provide antibacterial efficacy through both the
release of silver ions (Ag+) and through the direct action of metallic AgNPs (Ag0). The Ag+
provide antibacterial effects by permeating cell walls, damaging proteins and membranes and
causing oxidative stress20. The antibacterial action of Ag0 is by a similar permeation-based
toxicity, as well as through cell surface attachment and disturbances to the permeability and
metabolism of bacterial cells21,22.
Currently, surface modifications to titanium implants are limited commercially to surface
treatments (physical roughening, anodizing, chemical etching, etc.) and inorganic ceramic
coatings that typically incorporate hydroxyapatite (HA) as a bioactive layer. However, the
50

application of such ceramic coatings has numerous disadvantages such as slow processing
(biomimetism), high temperature application (plasma spraying) and overly thick or brittle film
deposition, which limit their ability to be loaded with process sensitive antimicrobials 23–25.
Therefore, there was significant interest in using alternative coating materials containing organic
components, which could improve the material properties and processability of coating materials
while retaining an adequate level of bioactivity within tissues.
One organic material being considered for coating applications is chitosan, which is a naturally
occurring polycationic polymer derived from the shells of crustaceans. Chitosan is both
biocompatible, biodegradable and has antibacterial effects. Due to these unique properties,
chitosan has already found use in multiple biomedical applications that include drug delivery26–
28

, tissue engineering29–31, ophthalmology32–34 and as medical device coatings35–37. However,

chitosan alone has a propensity to degrade and has weak mechanical properties in vivo that
would make it a poor choice as a coating for implantable titanium materials.
Therefore, the development of class II organic–inorganic hybrid materials that retain the biologic
benefits of polymers such as chitosan, while enhancing their physical properties, has been
proposed38–40. By covalently coupling biopolymers to inorganic precursors, hybrid materials
could be developed that retain their biocompatibility and have improved mechanical properties.
For example, gelatin has been utilized as the organic component in a class II hybrid framework
with silica, to develop highly porous scaffolds for bony tissue applications with tunable
mechanical and dissolution properties41. Similarly, chitosan has been shown to be an appropriate
biopolymer for covalent coupling with silica networks that are otherwise too brittle42–45.
Coupling with inorganic silica networks, in these cases, significantly improves the mechanical
properties of chitosan alone for applications as biomaterials. Similar studies have used chitosan
as a primary organic network modifier and sole antimicrobial agent in the development of
coatings for titanium implant materials46,47. These studies have shown that such materials could
promote bone forming ability and provide an antimicrobial effect against clinically relevant
pathogens. This study evaluated the robustness of these materials and investigated the inclusion
of AgNPs into the coating network to improve antimicrobial efficacy against both static and
planktonic pathogens.
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Therefore, the purpose of this research was to develop robust and functional chitosan–silica
coatings for titanium implants. The objective was to develop robust chitosan–silica class II
hybrid coatings that could be loaded with AgNPs for manifest antibacterial properties.
3.2 Materials and Methods
3.2.1 Synthesis of Coating Materials
All chemicals involved in the preparation of coating materials were purchased as laboratory
grade reagents from Sigma Aldrich (St. Louis, MO, USA), unless otherwise specified. There
were four formulations of chitosan–silica hybrid coating materials prepared (Table 1). Their
composition and preparation were identical, except for their organic content that varied from
20% to 80% by weight. The variation in organic content was achieved by modifying the ratio of
tetraethoxysilane (TEOS) to chitosan coupled with 3-glycidyloxypropyltrimethoxysilane (ChGPTMS).

Table 3.1 Composition of hybrid coatings.
80% Organic Blends 60% Organic Blends 40% Organic Blends 20% Organic Blends
80ChSi 80 ChSi-nAg 60ChSi 60ChSi-nAg 40ChSi 40ChSi-nAg 20 ChSi 20 ChSi-nAg
Ch-GPTMS a
80
80
60
60
40
40
20
20
TEOS b
20
20
40
40
60
60
80
80
AgNPs c
–
0.023
–
0.023
–
0.023
–
0.023
a
Chitosan coupled with 3-glycidyloxypropyltrimethoxysilane (network wt.%); b tetraethoxysilane (network
wt.%); c silver nanoparticles (total coating wt.%)
Components

A coupling reaction between chitosan and GPTMS was initiated as previously described42,45.
Briefly, chitosan (200 kDa, 82% DDA) was dissolved in an acidic solution (HCl, pH 4.0) to a
concentration of 18 mg/mL. This chitosan solution was strained through a cotton filter and then
GPTMS was added at a 1:1 molar ratio of solubilized chitosan to GPTMS and left to couple over
a period of 24 hours at room temperature. Following coupling, an appropriate amount of
hydrolyzed TEOS (pH 4.0) was added to the Ch-GPTMS solution to yield hybrids of varying
organic content (20, 40, 60 and 80 wt.%). The inorganic component of the hybrid material was
controlled independently using TEOS. After the addition of an appropriate amount of TEOS as

52

the inorganic component in the hybrid material, duplicate preparations of each coating material
were loaded with AgNPs (0.023 wt.%) and agitated maximally for 1 h.
The AgNPs were synthesized by a chemical reduction method, as previously described48–50.
Initially, a solution of NaBH4 (2.0 × 10–3 M) was prepared in double distilled water and chilled
in an ice bath for 15 min. Concurrently, a solution of AgNO3 (2.0 × 10–3 M) was prepared in
double distilled water. While the solution of NaBH4 was stirred vigorously, the solution of
AgNO3 was added dropwise with NaBH4 being in excess (NaBH4:AgNO3 6:1 v/v). Following the
addition of AgNO3, stirring was stopped and the AgNP colloid was stabilized with an
appropriate amount of polyvinylpyrrolidone (0.3 wt.% PVP) solution. The PVP stabilized AgNP
solutions were then subjected to repeated cycles of ultracentrifugation and freeze-drying to
collect concentrated AgNPs.
The synthesized AgNPs were examined by transmission electron microscopy (TEM). Nickel
grids (400 mesh) were dipped in aqueous suspensions of AgNPs and allowed to air-dry. Analysis
was performed using a Philips 420 TEM at an accelerating voltage of 80 kV equipped with an
AMT 4000 digital imaging system.
3.2.2 Deposition of Hybrid Coatings
Commercially available titanium alloy (Ti6Al4V) discs (9 × 9 × 2 mm) were polished with
silicon carbide study up to 1200 grit, then rinsed with acetone and washed by ultrasonication in
deionized water. Some discs were then immersed in a solution of HCl and H2SO4 in double
distilled water (2:2:1 v/v) at 65 °C for 20 min. Following this etching process, these discs were
neutralized with a NaHCO3 solution (0.5 M), washed by ultrasonication in deionized water and
ethanol and dried at 40 °C.
The polished and acid-etched Ti6Al4V discs were used as substrates for the application of
chitosan–silica class II hybrid coatings in a standard dip-coating protocol51. Briefly, the discs
were immersed in freshly prepared chitosan–silica sol using a dip and withdrawal speed of 100
mm/min. Following dip coating, the discs were dried in a vacuum oven at 80 °C for 3 h and then
stored at room temperature.

53

3.2.3 Characterization of Coating Surfaces
The hybrid coating surfaces were carefully analyzed for their chemical structure, composition
and microtopographies. The presence of covalent coupling between chitosan and GPTMS was
identified by solid–state nuclear magnetic resonance (NMR). 13C Magic-angle spinning (MAS)
NMR spectra were acquired at natural abundance on a 14.1 T Inova I600 NMR Spectrometer
(Varian Inc., Palo Alto, CA, USA) operating at 79.4 MHz. Hybrid coating samples were spun at
13 kHz using a 3.2 mm MAS HXY probe. In addition, the degree of covalent coupling was
measured with a ninhydrin assay as follows52,53. Briefly, a ninhydrin solution was added to solid
suspensions of the coating samples at 80 °C for 20 min. Solid suspensions were prepared by
grinding dried coating materials with a mortar and pestle and suspending the fine powder in
double distilled water. The absorbance of prepared suspensions was measured at 570 nm using a
spectrophotometer (G1103A, Agilent Technologies, Santa Barbara, CA, USA) and compared to
a standard curve prepared from the chitosan batch used in this study. Using the standard curve,
the percentage of free (uncoupled) amino groups present in the coating samples was calculated.
The surface morphologies and microtopographies of the hybrid coatings were examined by
scanning electron microscopy (SEM), using a Hitachi SU8230 Regulus Ultra High-Resolution
Field Emission SEM (Hitachi, Tokyo, Japan). The coated Ti6Al4V discs were secured to metal
stubs with carbon tape and sputter coated with 10 nm gold nanoparticles prior to analysis.
Additionally, elemental distribution maps of the coating surfaces were obtained by energydispersive X-ray spectroscopy (EDX) using a Bruker X-Flash FQ5060 Annular Quad EDX
detector (Brunker, Billerica, MA, USA).
The chemical structure of the coatings and the presence of key functional groups were analyzed
using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). Hybrid
coating samples were analyzed using a Bruker Tensor II system with a Platinum ATR (unit
A225) equipped with a 2 × 2 mm diamond crystal (Brunker, Billerica, MA, USA). Spectra were
acquired in the range of 4000–400 cm−1, at a resolution of 4 cm−1 and taken as an average of 32
scans. All spectra were analyzed using OPUS spectroscopy software.
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3.2.4 Evaluation of Mechanical Properties
The mechanical properties of the hybrid coatings and their interface with underlying titanium
substrates were carefully evaluated. Their surface energies were analyzed by measuring the
water contact angle for double distilled water. The water contact angles were measured by the
DataPhysics OCA 30 (DataPhysics, Filderstadt, Germany) using the sessile drop method. Drop
volume was maintained at 10 µL and replicate (n = 5) measurements were obtained.
Overall, adhesion of the hybrid coatings to their titanium substrates was evaluated qualitatively
using an abbreviated cross hatch adhesion protocol (ASTM D335954). Briefly, the coatings were
scored using a cross hatch cutter (Elcometer, Manchester, United Kingdom) with standardized
blade spacing (11 × 1 mm). There were two perpendicular cuts (20 mm) that were made with a
steady motion and force to penetrate the coating layer and create a lattice pattern. ASTM
standard tape was then placed over the center of the grid, smoothened with a pencil eraser and
then withdrawn in a steady motion at an angle of 180° from the substrate. Resultant defects in
the coating layer were examined using a brightfield microscope at a magnification of 50×
(Mitutoyo, Kanagawa, Japan).
Quantitative assessments of the coatings’ adhesion to titanium substrates and risks of
delamination were obtained through a tensile adhesion protocol as follows (Figure 3.1)55. The
coated Ti6Al4V discs were fixed to aluminum dolly specimens with T-88 epoxy resin (System
Three Resins, Inc., Lacey, WA, USA). The affixed samples were secured to a tension adapter in
an Adelaide TCC universal testing machine (Adelaide Testing Machines, Toronto, ON, Canada),
and forced apart at a speed of 3 mm/min. Each coating and treated titanium substrate were tested
in triplicate (n = 3). Following separation, the site of delamination was carefully examined, with
the coating adhesive strength calculated as:
Adhesive Stength (MPa) =

Load at Failure (N)
Coated Area (m2 )
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(1)

.
Figure 3.1 Adhesive tensile testing of hybrid coatings on titanium (Ti6Al4V) substrates. The
coating (black line) and Ti6Al4V substrate (red line) are forced apart (yellow arrows) in
an Adelaide TCC universal testing machine
3.2.5 Evaluation of Antimicrobial Properties
The antimicrobial properties of the hybrid coatings were evaluated against common Grampositive and -negative bacterial pathogens. Their antimicrobial efficacies were assessed
quantitatively against Escherichia coli (Gram-negative, ATCC® 25922) and Staphylococcus
aureus (Gram-positive, ATCC® 25923) suspended in planktonic bacterial cultures and on their
formation of adherent biofilms. Separate E. coli and S. aureus monocultures suspended in Luria
Bertani (LB) medium were prepared from inoculum.
The coated discs were disinfected and sterilized in preparation for bacterial cultures. They were
rinsed twice with ethanol (70% v/v), washed thrice with phosphate buffered saline (PBS), then
placed in a tissue culture hood and exposed to UV light for 30 minutes to ensure sterility.
Replicate coated discs (n = 3/coating) were submerged in each bacterial suspension of 105
CFU/mL and incubated at 37 °C under aerobic conditions. At predetermined times (1, 2, 4, …,
24 h), samples of the bacterial suspension were withdrawn and their absorbance (OD600)
measured using a spectrophotometer (Agilent Technologies, Santa Barbara, CA, USA). Viable
cells from the samples of bacterial suspension were counted by serial dilution and the spread
plate method using 100 × 15 mm LB Agar plates.
Additional sterile coated discs (n = 3/coating) were submerged in each bacterial suspension of
105 CFU/mL and incubated at 37 °C under aerobic conditions for a period of 24 h. Following
incubation, the coated discs were gently rinsed thrice with sterile PBS, transferred to sterile
culture tubes containing 2 mL of fresh LB medium and subjected to ultrasonication for 5 min.
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Viable bacteria were harvested from the sonicated samples and counted by serial dilution and the
spread plate method using 100 × 15 mm LB Agar plates. The inhibition of bacterial biofilm
formation was calculated with CFUcontrol representing colonies on uncoated control (Ti6Al4V)
surfaces and CFUcoating being the colonies on each coating as:

Bacterial Inhibition (%) =

CFUContol − CFUCoating
× 100
CFUControl

(2)

3.2.6 Statistical Analysis
The data in this study were analyzed using GraphPad Prism software (V 6.01). All data are
expressed as mean ± standard deviation. One-way ANOVA analyses were used to make
comparisons among multiple groups. Group differences were specified using Tukey’s post hoc
tests with the differences considered statistically significant when p < 0.05.
3.3 Results and Discussion
3.3.1 Characterization of Coating Materials
The first step in this research was to successfully synthesize class II hybrid coating materials.
Class II hybrids have been shown to display synergistic properties that complement the
advantages of both organic and inorganic polymers56. In this study, class II hybrid materials were
developed using chitosan as an organic polymer component, GPTMS as a silane coupling agent
and TEOS as an independent inorganic network agent. Initially, covalent coupling occurred
between the epoxide functional group of GPTMS and the primary amine group of chitosan
(Figure 3.2(A)). Concurrently, the acidic conditions of the reaction catalyzed the hydrolysis of
ethoxysilane bonds to form Si–OH pendants. Following coupling, pre-hydrolyzed TEOS was
added to the solution of functionalized chitosan, and polycondensation of the network proceeded
to occur through the formation of Si–O–Si linkages. After the addition of hydrolyzed TEOS,
some of the materials had aqueous suspensions of AgNPs added to their blend to create
antimicrobial coatings.
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Figure 3.2 Chemical synthesis of chitosan–silica Class II hybrids and imbedding of silver
nanoparticles (AgNPs). (A) Coupling of chitosan and 3glycidyloxypropyltrimethoxysilane (GPTMS) in mildly acidic conditions; (B)
polycondensation of coupled chitosan and hydrolyzed tetraethoxysilane (TEOS); (C)
imbedding AgNPs into the hybrid sol network.

To verify that these coating materials were indeed class II hybrids, it was essential to confirm
that there was covalent coupling between the organic and inorganic components. In this study,
the coupling of chitosan using its primary amine functionality to GPTMS was evaluated, because
the epoxide functional group of GPTMS is known to form covalent bonds with nucleophilic
functional groups such as amines under acidic conditions57. To observe these reactions between
GPTMS and chitosan, 13C MAS-NMR spectroscopy was used. The coupling reaction could be
followed by identifying the peak assignments previously described (Figure 3.3)43. The 13C
resonance labeled ‘6’ (associated with the carbon in the epoxide ring) at δ ~47 ppm, showed that
some of the epoxide rings of GPTMS had been opened by a nucleophilic attack of the primary
amine of chitosan to form a secondary amine. There were no other reactions between chitosan
and GPTMS identified, which indicated that the coupling occurred exclusively between the
primary amine of chitosan and the epoxide of GPTMS. Indeed, these findings are consistent with
what has been reported by others for the coupling of chitosan and GPTMS under similar
conditions43,45.
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Figure 3.3 Characterization of covalent coupling in hybrid materials. 13C Magic-angle spinning
nuclear magnetic resonance (MAS-NMR) spectra of the hybrid material. Covalent
coupling was confirmed by peak “6”, which was from a nucleophilic attack of the
primary amine in chitosan on the epoxide of 3-glycidyloxypropyltrimethoxysilane
(GPTMS). The absence of other peaks associated with coupling of these species indicated
that the amine in chitosan was the sole site of coupling.

As a method to conveniently measure the degree of covalent coupling between chitosan and
GPTMS, a ninhydrin assay was utilized (Figure 3.4). This assay enabled the detection of primary
amine groups that may have remained uncoupled during the development of the hybrid materials.
Through this colorimetric assay, the transformation of primary amines in the deacetylated units
of chitosan to secondary amines upon coupling with the epoxide functional group of GPTMS,
could be monitored.
A standard curve was established with the batch of chitosan used in this study, which had an
82% degree of deacetylation. It was compared to the chitosan coupled with GPTMS and showed
that a 91% degree of crosslinking between chitosan and GPTMS was achieved. This high degree
of coupling was closely monitored and maintained throughout the study, as variations in covalent
coupling can yield large variations in the mechanical and thermomechanical properties of the
resulting hybrid materials58.
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Figure 3.4 Quantitative analysis of covalent coupling between chitosan and 3glycidyloxypropyltrimethoxysilane (GPTMS) by ninhydrin assay. In finely ground
aqueous suspensions of coupled material (Ch+GPTMS) and uncoupled chitosan (MMW
Chitosan), ninhydrin reagents selectivity for primary amines was measured by optical
absorbance at 590 nm. The degree of covalent coupling between chitosan and GPTMS
was measured to be 91% and maintained throughout the study.

SEM was utilized to examine the roughened surface morphologies and microtopographies of the
hybrid coating films (Figure 3.5A). A common standardized acid-etching protocol was applied to
bare titanium to achieve a roughened substrate topography. To coat these roughened Ti6Al4V
substrates, a dip coating protocol was utilized that has been shown to effectively deposit thin
films from hybrid sols59–61. The thinness of the hybrid coating films ensured that there was a
degree of roughness attributed to their acid-etched substrates. The coated surfaces retained a
degree of microscale roughness that has been shown to provide a positive topographical stimulus
for cell interactions and bone apposition62–64.
The accompanying EDX analyses and elemental mapping of silicon, oxygen, nitrogen, carbon
and silver (Figure 3.5B–F)) showed their distribution across the coated surfaces. All elements
were found to be homogeneously distributed throughout the coating matrix for all samples. The
distribution of silicon (Figure 3.5B) confirmed the presence of silanol and siloxane networks in
the hybrid coatings and their homogenous nature throughout the matrix. The distribution of
nitrogen (Figure 3.5D) and carbon (Figure 3.5E) confirmed the presence of an organic chitosan
network that was homogenously integrated throughout the coatings. Additionally, the detection
of silver (Figure 3.5F) confirmed the successful incorporation and homogenous distribution of
antimicrobial AgNPs throughout the coating matrix.
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Figure 3.5 Scanning electron microscopy (SEM) and elemental (EDX) analysis of the 40%
ChSi-nAg hybrid coating. SEM showed smooth undulating contours and
microtopographies (A). EDX mapping detected a homogenous distribution of silicon (B),
oxygen (C), nitrogen (D), carbon (E) and silver (F). The SEM/EDX analyses were
representative and consistent across all coatings. Scale bar: 100 µm.

The AgNPs was synthesized through supplementary procedures. Their nanoscale dimensions
were confirmed by transmission electron microscopy (TEM). Micrographs (Figure 3.6A) showed
that all synthesized nanoparticles were under 100 nm in size and UV spectroscopy (Figure 3.6B)
confirmed the consistency of their colloidal suspensions. The PVP-capped nanoparticles
synthesized in this study, were maintained within 10–20 nm and exhibited long-term colloidal
stability in aqueous solutions, before being incorporated into the chitosan–silica hybrid sol–gel
system for coating.
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Figure 3.6 Evaluation of synthesized AgNPs. (A) Transmission electron microscopy (TEM)
confirmed nanoscale particle sizes. (B) UV spectroscopy of AgNP suspensions verified
their consistency.

Through the utilization of class II covalent coupling reactions, highly homogenous hybrid
coatings were created. The homogenous coating matrices are consistent with enhanced
mechanical properties. In contrast, coating materials that lack homogeneity have been shown to
have inconsistent mechanical properties and result in areas across coating surfaces that have
inconsistent resorption properties65,66. Indeed, a lack of homogeneity in the HA coating materials
that are currently available has limited their clinical usage and success. They have been shown to
suffer from phase inconsistency and resultant discrepancies in their mechanical properties67,68.
ATR-FTIR analyses were used to compare the variation in chemical properties between different
coating blends (Figure 3.7). For pure chitosan, the peaks associated with the stretching of the
primary and secondary amines were identified at 1526 cm-1 and 1635 cm-1, respectively. As
expected, these peaks decreased in intensity as the organic content of the hybrid coating blends
decreased (80%, 60%, 40% and 20% ChSi), and were completely absent for the purely inorganic
TEOS-based material. When comparing the intensity of these peaks for pure chitosan and the
coupled chitosan samples (Ch+GPTMS), there was a decrease observed in the relative intensities
for the primary amine in chitosan and no change for the secondary amine. This showed that the
coupling reaction had only occurred between the primary amine in chitosan and GPTMS,
confirming the findings of 13C MAS-NMR and the ninhydrin assay.
Additionally, the incorporation of GPTMS into these hybrid materials was detected by the bond
stretching associated with the epoxide group identified at 910 cm−1 (Figure 3.7). This epoxide
peak was observed in pure coupled samples (Ch+GPTMS) and faintly in the more highly organic
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blends (80% and 60% ChSi). As the inorganic fraction increased, this peak was progressively
eclipsed by the consequent stretching of the silanol species at 935 cm-1. The incorporation of
silane species into the hybrid coatings was observed as peaks from the stretching of the Si–OH
bond at 774 cm-1 and 935 cm−1 in the hydrolyzed material and the stretching of the Si–O–Si
bonds at 1065 cm-1 from condensed siloxane. As expected, the presence of these peaks became
more prevalent as the organic content decreased in the hybrid coating blends.

Figure 3.7 Infrared analyses of chemical structures in hybrid materials. Total reflectance Fourier
transform infrared (ATR-FTIR) spectra of chitosan, chitosan coupled with 3glycidyloxypropyltrimethoxysilane (Ch+GPTMS), hybrid materials (80%–20% ChSi)
and pure inorganic siloxane (condensed TEOS). There were more peaks attributed to
chitosan and GPTMS (-NH, -NH2, Epox) for hybrid materials with higher organic
content. Their chemical characteristics were more similar to a purely inorganic siloxane
network (Si–O–Si, Si–OH), as the organic fraction decreased.

3.3.2 Material Properties
For all biomaterials, surface interactions with surrounding physiological fluids that may include
the adsorption of serum proteins, are an important determinant of subsequent cellular responses
and the ingrowth of host tissues69. To predict these interactions, the measurement of water
contact angles on the biomaterial surfaces are an effective metric. Surfaces with contact angles
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between 60° and 85° are intermediate in hydrophilicity, and have been shown to facilitate the
most favorable interactions with host tissues through enhanced cell growth and
proliferation59,70,71.
All hybrid coatings that were developed in this study had an intermediate degree of
hydrophilicity (Figure 3.8). The coating blend with the least organic content (20% ChSi) had the
largest water contact angle and was a little more hydrophobic than the 60% ChSi blend, which
had the smallest contact angle and was the most hydrophilic. However, these differences
between the blends were small and not statistically significant (p > 0.05). However, all coatings
had contact angles that were larger than their uncoated acid-etched Ti6Al4V substrate and these
differences were statistically significant (p < 0.05). Although the coating blends contained many
hydrophilic chemistries due to their chitosan content and the remaining silanol linkages, the bare
acid-etched Ti6Al4V substrates had a high degree of surface roughness, which enhanced their
wettability. For such wettable surfaces (contact angles < 90°), an increase in surface roughness
has been reported to enhance their hydrophilicity72. The acid-etching of Ti6Al4V substrates
created numerous pits and valleys ranging in size from 10–40 µm (Figure 3.9), which enhanced
their surface roughness and thereby their hydrophilicity. The deposition of coatings on these
substrates partially filled these pits and valleys, which reduced their surface roughness and
increased water contact angles.

Figure 3.8 Water contact angles for coatings and titanium (Ti6Al4V) substrates. Static water
contact angles (n = 5/surface) for all coatings and polished Ti6Al4V were similar with an
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intermediate degree of hydrophilicity. Contact angles for acid-etched Ti6Al4V were
significantly (p < 0.05) lower and more hydrophilic. ns—not significantly different; *—
statistically significant difference.

Figure 3.9 Scanning electron microscopy (SEM) of titanium (Ti6Al4V) substrates and coated
surfaces. (A) Polished Ti6Al4V was flat with smoothly scalloped surfaces; (B) acid-etched
Ti6Al4V had extensive surface fissures that created microscale roughness; (C) hybrid coating
(60% ChSi) films on acid-etched Ti6Al4V substrates retained microtopographical features and
surface roughness. SEM analyses were representative and consistent across all coatings.

Biomaterial coatings also require adequate adhesive bond strength to their underlying substrates,
which is an important parameter that is often overlooked in many studies. Poor adhesive strength
may lead to delamination of the coating, which then causes inflammation, bone resorption,
loosening of the fixtures and eventually the failure of intraosseous implants73,74.
Initially, the adhesion of the hybrid coatings to Ti6Al4V substrates was evaluated by a crosshatch delamination protocol as described in ASTM D3359. This method provided a coarse
assessment of overall coating adhesion. Additionally, the scoring of the coating materials
imparted stresses within their structure, which manifest as extensive cracks and fissures across
the surfaces of the purely inorganic controls (Figure 3.10C,D). The purely inorganic coatings
were brittle, and cross-hatch testing had led to a widespread cracking of their thin films. In
clinical applications, the impact of sharp boney protrusions and/or surgical instruments could
lead to a premature failure of such coatings in vivo75. In contrast, all hybrid coatings exhibited
highly robust, intact and integrated surfaces, despite the surface scoring (Figure 3.10A–B).
Additionally, more rigorous and quantitative evaluations of coating adhesion and risk of
delamination were performed by adhesive tensile tests based on established protocols55,76. All
coatings were assessed for their adhesion to both polished and acid-etched Ti6Al4V substrates
(Figure 3.11). All hybrid coatings were significantly (p < 0.05) more adherent to acid-etched
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Ti6Al4V substrates than to polished titanium. Furthermore, all coating blends that contained
AgNPs exhibited identical adhesion characteristics to those without these antimicrobial additives
(excluded from figure to ensure clarity). As expected, acid-etching like other surface roughening
pretreatments, enhances adherence to the modified substrate77–79. This has been attributed to the
increase in bonding area by roughening pretreatments, which thereby enhance the mechanical
adhesion of coatings to their substrates. However, purely organic chitosan control coatings
showed only a small, statistically insignificant (p > 0.05) increase in adhesion to the acid-etched
substrate compared to polished Ti6Al4V. This may have been due to the high viscosity of pure
chitosan, which led to poor wetting of Ti6Al4V substrates, and lower overall mechanical
adhesion compared to that of hybrid coating blends79.
Among implant coating materials that are commercially available, plasma sprayed
hydroxyapatite (HA) surfaces remain a gold standard for intraosseous applications. However,
their preparations involve high temperatures and variable cooling cycles, which retain residual
stresses that contribute to failures from adhesive forces of less than 10 MPa80–82. Therefore, the
robust adhesion (16–18 MPa) for all hybrid coatings deposited on acid-etched Ti6Al4V that were
developed in this research, warrant further study.

Figure 3.10 Microscopic examination of coatings in cross-hatch tests of adhesion. (A,B) Coating
(60% ChSi) surfaces were unblemished by full-depth incisions in the standardized cross66

hatch adhesion protocol; (C,D) inorganic siloxane material (control) developed extensive
arrays of surface cracks and fissures from the same cross-hatch testing protocol.
Adhesion of the 60% ChSi coating blend was representative and consistent across all
hybrid coatings.

Figure 3.11 Adhesive tensile strengths of coatings and chitosan on titanium (Ti6Al4V)
substrates. All hybrid coatings (n = 3/surface) had significantly (p < 0.05) more adhesion
to acid-etched than to polished Ti6Al4V substrates. All hybrid coatings were more
adhesive than pure chitosan to both polished and acid-etched Ti6Al4V. *—statistically
significant difference

3.3.3 Antimicrobial Properties
As bacterial infections are the most common cause of implant failure7–9, the application of
antimicrobial surface coatings may afford a valuable feature for implantable materials.
Therefore, the coatings in this study were prepared with chitosan as the main organic constituent,
which naturally displays some antimicrobial activity. Additionally, some of these coatings were
loaded with AgNPs as additives that could further enhance their antimicrobial effects.
Antimicrobial efficacies were evaluated on S. aureus and E. coli cultures, which are common
Gram-positive and Gram-negative bacterial pathogens, respectively, associated with various
bodily infections.
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Interestingly, the S. aureus and E. coli cultures were only minimally affected by the base
coatings that had not been loaded with AgNPs (Figure 3.12). However, E. coli growth was
markedly reduced over 24 h, and S. aureus growth was completely suppressed for 24 h, with all
coatings that contained AgNPs.

Figure 3.12 Inhibition of bacterial growth in planktonic cultures. There was a (A) marked
reduction in E. coli growth and (B) complete inhibition of S. aureus grown in the
presence of 80% ChSi-nAg compared to 80% ChSi. This inhibition of bacterial growth
by 80% ChSi-nAg was representative and consistent for all hybrid coatings that contained
AgNPs.

The quantitative assessments of these bacterial cultures following 24 h incubations with hybrid
coatings showed that there had been some inhibition by all coatings, when compared to uncoated
titanium controls (Figure 3.13). The planktonic E. coli and S. aureus cultures were almost
completely inhibited (80%–100% and 75%–77%, respectively) by the presence of coatings that
had been loaded with AgNPs. Indeed, coatings loaded with AgNPs were significantly (p < 0.05)
more effective than base coatings without AgNPs, which had only minimal antibacterial effects
(<30%). These results indicated that release-based mechanisms were involved in the
antimicrobial properties of the hybrid coatings. They were bacteriostatic and/or bactericidal
effects on some of the most common bacterial pathogens that cause opportunistic infections.
Additionally, coatings loaded with AgNPs appeared to have been more effective against E. coli
cultures, than S. aureus. This difference may have been due to the release-based antimicrobial
action of AgNPs through the different cell wall structures of these bacteria. Unlike Gramnegative E. coli planktonic cells, Gram-positive bacteria such as S. aureus are protected from
their external environment by much thicker peptidoglycan layers within their cell walls83. These
68

cell walls may have partially limited the internalization of AgNPs and retarded their releasebased action. Similarly, previous studies have reported that Gram-negative bacteria experienced
more membrane damage and oxidative stress in response to the release-based action of AgNPs,
than Gram-positive bacteria84–86.

Figure 3.13 Inhibition of bacterial cultures by hybrid coatings with (+) and without (−) AgNPs.
(A) E. coli and (B) S. aureus cultures were inhibited by incubation (24 hours) with all
hybrid coatings, compared to uncoated titanium (Ti6Al4V) controls. There was little
inhibition from base coatings without AgNPs, but significantly (p < 0.05) more and
almost total inhibition for coatings loaded with AgNPs.

In addition to the virulence of planktonic cells within bacterial cultures, these pathogens can be
particularly pernicious due to their formation of highly adherent biofilms on biomaterial
surfaces. In contrast to cells suspended in culture, bacteria encased within biofilms are highly
resistant to mechanical dislodgement and antibiotic treatment8,10. Therefore, E. coli and S. aureus
biofilm formation on coatings were carefully compared to uncoated Ti6Al4V controls for
inhibitory effects.
Indeed, both E. coli and S. aureus were clearly inhibited for at least 24 h in their formation of
biofilms on all hybrid coatings, compared to uncoated Ti6Al4V controls (Figure 3.14). Base
coatings alone were moderately effective at inhibiting E. coli biofilm formation on their surfaces
(31%–50%) and were even more effective against S. aureus (38%–80%). However, the coatings
loaded with AgNPs were markedly more effective at inhibiting E. coli biofilm formation (60%–
95%), and almost completely effective against S. aureus (90%–95%). The coatings with AgNPs
were significantly (p < 0.05) more effective than their unloaded controls for all blends, except
those that had a high organic chitosan content. This accompanied the positive trend of greater
antimicrobial activity with increasing chitosan content. As chitosan is a naturally antimicrobial
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polysaccharide, its role in the coating network was expected to have had this effect on both the
inhibition of biofilm formation and the inhibition of bacterial cultures87.
The larger inhibition of S. aureus compared to E. coli biofilms contrasted with the reduced
susceptibility of S. aureus than E. coli cells in culture. This may have been due to differences in
their development of extracellular polymeric substances (EPS). Mainly composed of
polysaccharides and proteins, the EPS produced by sessile colonies of bacteria has been shown
to be a key component in their resistance to antibiofilm agents such as cationic peptides and
metal ions88. Additionally, the EPS production of sessile colonies has been shown to be enhanced
when colonies adhere to toxic surfaces89. Therefore, the sessile colonies of E. coli may have
provided some resistance to the coatings by producing more EPS during biofilm formation.
Indeed, prior studies have reported that E. coli exhibit rapid EPS formation when compared to
their Gram-positive counterparts, leading to a more effective resistance in their sessile state84,90.

Figure 3.14 Inhibition of bacterial biofilm formation on hybrid coatings with (+) and without (−)
AgNPs. (A) E. coli and (B) S. aureus biofilm formation (24 h) were inhibited on all
hybrid coatings, compared to uncoated titanium (Ti6Al4V) controls. Inhibition of biofilm
formation was greater on coatings that contained AgNPs and was generally more on
coatings with higher organic content. There was near complete inhibition of S. aureus
biofilms on all hybrid coatings that contained AgNPs.

3.4 Conclusions
In this study, chitosan–silica class II hybrid materials were developed as thin film coatings for
implantable Ti6Al4V surfaces. Additionally, the hybrid coatings were effectively loaded with
AgNPs for antimicrobial applications. Their chemical structures and composition were
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confirmed by MAS-NMR, FTIR and EDX analyses. Surface microtopographies, mechanical
properties and wettability were evaluated by SEM, adhesive tensile testing and water contact
angles. Antimicrobial properties were assessed in E. coli and S. aureus cultures and on their
biofilm formation.
The hybrid coatings demonstrated strong covalent linkages between their organic chitosan
backbone and the silica inorganic network. There was a homogenous dispersion of elements,
including AgNP additives, across their surfaces. Hybrid coatings demonstrated a robust
resistance to fracture and dislodgement and were highly adherent to acid-etched Ti6Al4V
substrates, especially when compared to purely organic or inorganic materials. They exhibited
moderate levels of roughness, microtopography and wettability when compared with uncoated
Ti6Al4V surfaces. All hybrid coatings displayed some antimicrobial effects and greater organic
chitosan content was associated with increased bacterial inhibition. Additionally, coatings loaded
with AgNPs showed marked inhibition of planktonic bacteria and their biofilms, with near
complete inhibition of E. coli cultures and of S. aureus biofilm formation. These robust, retentive
and antimicrobial coatings for implantable titanium materials were based on rudimentary
chitosan–silica coupling processes, which may afford a novel strategy for biomaterial
applications.
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Chapter 4: Development of multifunctional bioactive implant
coatings using a novel calcium precursor to improve
osseointegration and antimicrobial effectiveness
4.1 Introduction
Over the past half century, titanium (Ti) and its alloys have become ubiquitous within
implantology as materials of choice for augmenting and restoring function to human tissues1,2.
They endure conditions of high-loading and/or repetitive cycling while remaining resistant to
chipping and fracture, and possess the appropriate moduli that limit adverse effects from stress
shielding seen with other metallic implant materials3–5. Addionally, the titanium dioxide layer
that forms on the surface of these materials resists corrosion and provides a highly inert and
biocompatible platform for interactions with surrounding cells and tissues. However, the inherent
inertia of titanium surfaces is accompanied by a failure to alleviate two frequent complications in
implantology. These are implant associated infections from surface microbes and aseptic
loosening from lack of fixation, which pose major challenges to their long-term success and
survival in clinical practice.
Despite widespread use of aseptic surgical techniques, implant associated infections continue to
pose a threat of complications to their integration and retention within host tissues. Currently, the
risk of postoperative infections associated with hard tissue implantations range from 2-5% for
orthopaedic procedures, and 4-11.5% for dental and oral surgeries6–8. They can be caused by any
bacteria or fungi but are most commonly due to bacterial staphylococci. These include the
common pathogen Staphylococcus aureus (S. aureus) and the ubiquitous Staphylococcus
epidermidis (S. epidermidis)9,10 that are prevalent on human skin, and readily form biofilms on
implant surfaces11. The biofilms consist of bacterial cells encased within their own
polysaccharide matrix, which are highly adherent and resistant on biomaterial surfaces. As the
biofilms mature they present a favourable environment for symbiotic microbes such as
Escherichia coli and Pseudomonas aeruginosa to become established within polymicrobial
communities12. These mature polymicrobial biofilms can be up to a thousand times more
resistant to antibiotics than bacterial cells that are suspended in a planktonic state7,13.
Accordingly, the infections require complex treatments that include complete removal of the
implanted protheses and significant debridement of host tissues14.
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Although implant associated infections are the primary cause of implant failures, the aseptic
loosening of implants without microbial infections are another complication that occurs. Indeed,
aseptic loosening may account for up to 36% of implant failures in joint arthroplasty15. These
implants lack fixation and adequate osseointegration within host tissues16, and the resultant
micromotions of the prosthesis may cause fibrous tissue formation, which exacerbates their
loosening. Therefore, current strategies to enhance osseointegration are to promote bone
deposition on implant surfaces with ceramic coatings containing calcium phosphates (CaP),
hydroxyapatites (HA) and materials containing calcium, silica, phosphorous and magnesium 17–
20

. However, these ceramic coatings are plagued by inconsistent properties from poor processing

conditions that risk their delamination under clinical wear21,22.
Therefore, implant surfaces need to both prevent infections and promote bone deposition to
ensure success. Immediately following their surgical placement, both host tissue cells and
contaminant microbes participate in a “race to the surface” of the biomaterial, where the fate of
the implant is determined by which surface colonizers prevail12. Although current strategies may
be effective at either goal, few are proficient in both domains. Therefore, multifunctional
surfaces that both promotes bone apposition and prevent microbial colonization are sorely
needed for implants.
To develop such multifunctional implant coatings, the application of amorphous ceramic
materials by using sol-gel techniques has shown promise. Sol-gel ceramic synthesis involves the
hydrolysis and condensation of liquid ceramic precursors under low temperatures. The lower
temperatures result in higher porosity and surface area for the materials compared to traditional
melt-quench glasses, which promotes cell adhesion and tissue ingrowth23. Additionally, these
solution-based low temperature preparations allow homogeneous loading of process-sensitive
antimicrobials. Accordingly, such multifunctional sol-gel materials have been developed as
beads/particles, scaffolds, and fibers24–26, but their inherent brittleness and poor adhesive tensile
strength have limited their application as implant surfaces. Furthermore, the inclusion of calcium
to induce apatite formation has not been successfully incorporated into these sol-gel
preparations, under low temperatures or non-toxic synthesis conditions.
The sol-gel ceramics mechanical properties can be improved by including organic polymers as
composite and hybrid systems. However, simple blending of organic and inorganic networks
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creates inhomogeneous sol-gel composites with mismatched degradation rates, which are
unstable and deteriorate prematurely24,27. Alternatively, hybrid materials with molecular
interactions between their organic and inorganic phases have significantly more stability than
composites. Furthermore, hybrids with strong covalent interactions between organic and
inorganic components (class II) have advantages over those with weaker molecular forces (class
I). These class II hybrids act as single-phase materials exhibiting improved mechanical
properties and can be tailored to the needs of a variety of biomedical applications26,28–30.
Sol-gel materials can be further enhanced by including calcium as an osteoconductive factor.
Most commonly, calcium salts are added by high temperature processing in order to remove their
toxic salt biproducts. However, such processing precludes the use of temperature-sensitive
organic polymers and organosilanes such as GPTMS within hybrid sol-gel materials. Therefore,
calcium alkoxides are now being investigated as precursors for the inorganic portion of sol-gel
hybrid materials. They participate in the same network forming hydrolysis and condensation
reactions as traditional silica precursors, which allows simple integration into sol networks at
room temperature. However, most calcium alkoxides are highly sensitive to hydrolysis and
condensation reactions in the presence of water. Their instability in aqueous systems leads to
premature gelation of the inorganic network, which leads to poor and inhomogeneous integration
of calcium into materials. Additionally, incompletely hydrolyzed calcium alkoxides can leach
toxic by-products such as methanol from calcium methoxide and calcium methoxyethoxide.
Accordingly, water-tolerant and non-toxic calcium alkoxides need to be explored.
The purpose of this study was to develop robust multifunctional class II organic-inorganic hybrid
coating materials for titanium implants. For the organic phase, PEG-amine was synthesized and
coupled to GPTMS. The inorganic phase consisted of silica, and calcium was integrated into the
sol-gel network with newly developed calcium 2-ethoxyethoxide (Ca2EE). Ca2EE, was stable in
aqueous systems and homogeneously integrated into the hybrid coating network. These coating
matrices were loaded with silver nanoparticles (AgNPs) that inhibited bacterial growth and
biofilm formation.
4.2 Materials and Methods
All chemicals involved in the preparation of coating materials were purchased as laboratory
grade reagents from Sigma Aldrich (St. Louis, MO, USA), unless otherwise specified.
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4.2.1 Synthesis of Coating Materials
Synthesis of Ca2EE
Calcium-2-ethoxyethoxide (Ca2EE) was synthesized under similar conditions as other metallic
2-ethoxyethoxides previously described31. Dry distilled 2-ethoxyethanol (Caledon Laboratories,
Georgetown, ON, Canada) was heated to 80°C under an argon atmosphere. Calcium granules
(Alfa Aesar, Tewksbury, MA, USA) were slowly introduced into the heated vessel through a
pressure-equalizing funnel with maximal magnetic stirring. After adding metallic calcium, the
vessel was heated to 125°C and left to react for 20 hours. Then, Ca2EE was purified by
removing excess 2-ethoxyethanol through vacuum drying at 100°C for 6 hours. The Ca2EE
structure was confirmed by 13C NMR and spectral data agreed with previous reports32.
Functionalization of PEG
Amine functionalized polyethylene glycol (PEG) was prepared for its capacity to covalently
couple with inorganic silica networks as follows. PEG ditosylate (2k, 30g) was added to an
ammonium hydroxide solution (105 mL, 7.5 M) and stirred at room temperature for 5 days. The
resulting solution was washed (5x) with dichloromethane (5 x 100 mL), and the organic phase
separated and dried over anhydrous magnesium sulfate, followed by concentration and
precipitation with cold diethyl ether. The precipitate (PEG-diamine) was dried by vacuum
filtration and collected as a white powder. The PEG-diamine structure was confirmed by 1H
NMR and spectral data agreed with previous reports33,34.
Silane coupling of PEG-NH2
PEG diamine and 3-glycidyloxypropyltrimethoxysilane (GPTMS) coupling reactions were
initiated by methods similar to those previously described 35–37. PEG-diamine was dissolved in
absolute ethanol to a concentration of 40mg/mL. GPTMS was added to this solution at a ratio of
1:2 of PEG-diamine to GPTMS and left to couple under an inert nitrogen atmosphere at room
temperature for 24 hours.
Synthesis of AgNPs
Silver nanoparticles (AgNPs) were synthesized by a chemical reduction method previously
described38–40. NaBH4 solution (2.0 x 10-3 M) was prepared in double distilled water and placed
in an ice bath for 15 minutes. Chilled NaBH4 was agitated by rapid magnetic stirring, and
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AgNO3 solution (2.0 x 10-3 M) was added dropwise at a ratio of 1:6 (v/v) of AgNO3 to NaBH4.
Following the addition of AgNO3, the AgNP suspension was stabilized with
polyvinylpyrrolidone solution (0.3wt%). AgNPs were extracted by ultracentrifugation and
freeze-drying.
Preparation of hybrid materials
Class II organic-inorganic hybrid materials were synthesized with coupled PEG-NH2-GPTMS as
the organic phase (20wt%) and Si/Ca as the inorganic (80wt%). The molar ratio of Si/Ca (70:30)
matched that of traditional bioactive glasses. Tetraethoxysilane (TEOS) and HCl (1N) were
added to double distilled water at a ratio of 10:1:3 (v/v) under an inert nitrogen atmosphere and
allowed to react for 15 minutes. Si-functionalized PEG-NH2 was diluted in absolute ethanol and
added to the hydrolyzed TEOS solution with stirring for 5 minutes. Then, freshly prepared
Ca2EE was slowly added to the reaction vessel with rapid stirring over 40 minutes. After the
addition of Ca2EE, antibacterial coating blends were loaded with AgNPs (0.023wt%) with rapid
stirring for 10 minutes.

Table 4.1 Composition of Si-Ca-PEG based coatings
Inorganic Bioactive Glass
Components

Hybrid Bioactive Glass

Si-Ca2EE

Si-Ca2EE-nAg

Si-Ca-PEG

Si-Ca-PEG-nAg

TEOSa

70

70

56

56

Ca2EEb

30

30

24

24

PEGGPTMSc

0

0

20

20

AgNPsd

0

0.023

0

0.023

a

tetraethoxysilane (network wt%); b calcium-2-ethoxyethoxide (network wt%); c PEG-diamine coupled with 3glycidyloxypropyltrimethoxysilane (network wt%); d silver nanoparticles (total coating wt%)

Deposition of Hybrid Coatings
Ti6Al4V (9 x 9 x 2 mm) discs were prepared as substrates for the application of hybrid coatings.
All discs were polished with silicon carbide paper up to 1200 grit. They were degreased and
cleaned with acetone and deionized water by ultrasonication, and dried at 40°C. Additionally,
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some discs were acid-etched by immersion in a HCl and H2SO4 solution (2:2:1 v/v) at 65°C for
20 minutes. Following etching, discs were neutralized in a NaHCO3 solution (0.5 M) and cleaned
as detailed above.
Freshly prepared hybrid materials were deposited onto polished and acid-etched Ti6Al4V discs
by using a standard dip-coating protocol41. The discs were dipped and withdrawn from hybrid
solutions at a speed of 100 mm/min, dried in a vacuum oven at 80°C for 3 hours, and then stored
at room temperature.
4.2.2 Characterization of Coating Materials
Hybrid coating materials were analyzed for their composition, chemical structures, and surface
topographies.
Chemical Structures
Chemical structures were analyzed for the presence of bonds and key functional groups by using
attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). Hybrid
materials were ground into a fine powder with mortar and pestle, and analyzed in a Bruker
Tensor II system with a Platinum ATR (unit A225) equipped with a 2 x 2 mm diamond crystal
(Brunker, Billerica, MA, USA). Spectra were acquired in the 4000-400 cm-1 range, at 4 cm-1
resolution, averaged from 32 scans and analyzed using OPUS spectroscopy software.
Surface Properties
Surface morphologies and micro-topographies were examined by scanning electron microscopy
(SEM), and elemental distributions were analyzed by energy-dispersive X-ray spectroscopy
(EDX). The coated discs were affixed to metal stubs with carbon tape and sputter coated with 10
nm gold nanoparticles. Coatings surface features were visualized using a Hitachi SU8230
Regulus Ultra High-Resolution Field Emission SEM (Hitachi, Tokyo, Japan), and elemental
mapping was obtained by from a Bruker X-Flash FQ5060 Annular Quad EDX detector (Brunker,
Billerica, MA, USA).
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4.2.3 Evaluation of Mechanical Properties
Adhesive Strength
Quantitative assessment of the hybrid coatings adhesion to titanium substrates was further
evaluated using an established tensile adhesion protocol42. Briefly, coated Ti6Al4V discs were
first secured to aluminum dollies using T-88 epoxy resin (System Three Resins, Inc., Lacey,
WA, USA). Secured specimens were then seated in a tensile adapter in an Adelaide TCC
universal testing machine (Adelaide Testing Machines, Toronto, ON, Canada), and slowly forced
apart at a speed of 3 mm/min. Measurements for each coating and titanium surface treatment
were tested in triplicate with the method of separation closely examined for the point of
delamination. Using the load at failure and contact area of the aluminum dolly with the coated Ti
disc, the adhesive strength of coating materials were calculated as:

Adhesive Stength (MPa) =

Load at Failure (N)
Coated Area (m2 )

(1)

4.2.4 Evaluation of Biological Properties
Mineral Bioactivity
Mineral bioactivities were evaluated by immersion of coatings in simulated body fluid (SBF),
prepared as previously described by Kokubo et al43. For this preparation, NaCl, NaHCO3, KCl,
K2HPO4·3H2O, MgCl2·6H2O, CaCl2 and Na2SO4 were dissolved in double distilled water and
buffered to pH 7.4 using tris-(hydroxymethyl)-aminomethane ((CH2OH)3CNH2) and HCl. The
resulting simulated body fluid solution had an ionic composition that was similar to that of
human blood plasma (Table 2).

Table 4.2 Ionic composition of simulated body fluid and human blood plasma
[mM]

Na+

K+

Mg2+

Ca2+

Cl-

HCO3-

HPO42- SO42-

Body Fluid43

142

5

1.5

2.5

148.8

4.2

1

0.5

Blood Plasma

142

5

1.5

2.5

103

27

1

0.5
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Monoliths (100 mg) of coatings were immersed in 200 mL of simulated body fluid at 37°C for
72 hours. Following immersion, coating monoliths were rinsed with ethanol and double distilled
water and dried in a desiccator. Their dried surfaces were analyzed for the presence of
crystallized apatite by using scanning electron microscopy (SEM) and energy-dispersive X-ray
spectroscopy (EDX).
Antimicrobial Efficacy
The antimicrobial properties of base and AgNP loaded hybrid coatings were evaluated on
common Gram-positive and Gram-negative bacterial pathogens. Their antibacterial effects
against Staphylococcus aureus (Gram-positive, ATCC® 25923) and Escherichia coli (Gramnegative, ATCC® 25922) in monocultures and within single species biofilms were assessed.
Separate monocultures of E. coli and S. Aureus were prepared from inoculum and suspended in
Luria Bertani (LB) media for growth.
For these assessments, the coated Ti6Al4V discs were cleaned, disinfected and sterilized as
follows. The coated discs were rinsed twice with ethanol (70% v/v), washed thrice with
phosphate buffered saline (PBS), then placed in a tissue culture hood and exposed to UV light
for 30 minutes to ensure sterility. For each assay, replicate coated discs (n=3/coating) were
submerged in each bacterial suspension (105 CFU/mL) and incubated under aerobic conditions at
37°C.
To measure cell growth and survival in the planktonic state, samples of bacterial cultures grown
around coatings were withdrawn after 24 hours. Diluted samples were measured for their
absorbance (OD600) using a spectrophotometer (Agilent Technologies, Santa Barbara, CA).
Following 24 hours of incubation, viable cells from bacterial suspensions were counted by serial
dilution and the spread plate method using 100 x 15 mm LB Agar plates.
To measure cell formation of biofilms, the coatings submerged within each bacterial suspension
were withdrawn following 24 hours incubation. These coated discs were gently rinsed thrice with
sterile phosphate buffered saline (PBS) to remove non-adherent cells and transferred to sterile
culture tubes containing 2 mL of fresh LB media. They were then ultrasonicated for 5 minutes to
dislodge adherent cells from biofilms. Viable bacteria from sonicated samples were harvested
and counted by serial dilution and the spread plate method using 100 x 15 mm LB Agar plates.
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The inhibition of bacterial growth by each coating for both non-adherent (planktonic) and
adherent (biofilm) bacteria was calculated from the plate counts. Using the colonies for uncoated
Ti6Al4V discs as the control (CFUcontrol) and the colonies counted for each hybrid coating
surface (CFUcoating), bacterial inhibition was calculated as:

Bacterial Inhibition (%) =

CFUContol − CFUCoating
× 100
CFUControl

(2)

4.2.5 Statistical Analysis
The data in this study were analyzed using GraphPad Prism software (V 6.01). All data are
expressed as mean ± standard deviation. One-way ANOVA analyses were used to make
comparisons among multiple groups. Group differences were specified using Tukey’s post hoc
tests with the differences considered statistically significant when p < 0.05.
4.3 Results and Discussion
4.3.1 Characterization of Coating Materials
Hybrid precursor identification and synthesis
The first step in this work was to identify and synthesize an appropriate calcium alkoxide
precursor for use within the bioactive glass network. Indeed, the use of calcium alkoxides have
been shown to enable successful integration of calcium into silicate networks at low
temperatures 44. Calcium 2-ethoxyethoxide (Ca2EE) was identified as a potential calcium
precursor due to its structural stability in aqueous environments and non-toxic degradation byproducts. Most previously investigated calcium alkoxide precursors, such as calcium 2methoxyethoxide (CME), have been unstable in sol-gel systems containing water, which can lead
to poor hybridization and premature gelation of network structures 45–47. Despite the relative
instability of CME, promise exists in the use of similar longer ligand Ca-2-alkoxyalkoxides as
they are able to form water-stabilizing chelate cycles enabled through the presence of their
secondary ether group31. Along with their sensitivity to water, previously used calcium alkoxide
precursors have possessed the potential to leach toxic degradation by-products from bioactive
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glass materials. For example, calcium precursors such as CME and calcium methoxide (CM)
have the potential to leach methanol from bioactive glass materials if their ligands remain
uncondensed during network formation which could elicit a degree of cytotoxicity. Ca2EE, if left
uncondensed within bioactive glass materials, could instead leach ethanol, mitigating the
potential for a developed bioactive glass material to exhibit toxicity in vivo.
While this compound has been synthesized in previous works, it has not yet been utilized as a
network precursor for bioactive glass materials. One of the primary reasons for this is that
traditional methods for synthesizing calcium-2-ethoxyethoxide required the use of a toxic
catalyst (mercury (II) chloride), rendering the material unsuitable for biological applications48. In
this study, Ca2EE was synthesized in the absence of mercury (II) chloride to enable its use
within bioactive glass materials. Using 13C NMR, the successful synthesis of Ca2EE was
confirmed through observation of the pronounced deshielding of the Ca-O adjacent carbon
compared to that of the parent alcohol (2-ethoxyethanol) (Figure 4.1). Addionally, the doublets
appearing at C-1 and C-3, characteristic of bridging and non-bridging carbon resonances, further
confirmed the synthesis of Ca2EE, and were consistent with that of previous work32.

Figure 4.1 13C NMR of synthesized calcium-2-ethoxythoxide (Ca2EE)
The next step in this work was to identify and synthesize an appropriate organic polymer for use
within the hybrid bioactive glass network. Hydrophilic organic polymers have often been
identified as ideal class II precursors due to their ability to improve the flexibility of hybrid
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materials and improve their ability to participate in ion exchange with physiological fluids. For
this reason, poly(ethylene) glycol (PEG) was identified as the ideal given its flexible solubility
parameters and well established biocompatible and bioresorbable nature 29,49. To be successfully
integrated into the hybrid network, PEG was amine-functionalized to enable its coupling to a
silane precursor. Amine functionalization was selected due to the well-established coupling
reaction between amine-bearing polymers through the epoxide of GPTMS 30,50. The synthesis of
PEG-diamine was confirmed though 1H-NMR (Figure 4.2).

Figure 4.2 1H NMR of synthesized PEG-diamine (2K)

Hybrid Bioactive Glass Synthesis
In this study, class II hybrid bioactive glass materials were developed using PEG-diamine as an
organic polymer component, GPTMS as a silane coupling agent, Ca2EE as a calcium source, and
TEOS as an inorganic silicate networking agent. Initially, covalent coupling occurred between
the epoxide functional group of GPTMS and the primary amine groups of PEG-diamine (Figure
4.3(1)). Additionally, during the acidic conditions of this reaction, the ethoxysilane bonds of
GPTMS were hydrolyzed to form Si-OH pendants. Following coupling, silane-functionalized
PEG-diamine was added to a pre-hydrolyzed solution of TEOS to homogenize. Shortly after the
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addition of silane-functionalized PEG-diamine, Ca2EE was added slowly to the reaction vessel
to allow for the covalent introduction of calcium and continued polycondensation of the silicate
network. Following the reaction of the above-mentioned reagents, antibacterial coating materials
were developed through the simple addition of PVP-stabilized AgNPs.

Figure 4.3 Chemical synthesis of PEG–Ca-silica Class II hybrids and imbedding of silver
nanoparticles (AgNPs). (1) Coupling of PEG-amine and 3glycpidyloxypropyltrimethoxysilane (GPTMS) in mildly acidic conditions; (2)
polycondensation of coupled PEG-amine, calcium 2-ethoxyethoxide, and hydrolyzed
tetraethoxysilane (TEOS); (3) imbedding AgNPs into the hybrid sol network.

For synthesized PEG-diamine, it was important to identify the characteristic organic portions of
the polymer (Figure 4.4). The primary amines present in the structure were identified at 1570cm1

and the associated -CH backbone bending was identified at 1466cm-1. Upon coupling with

GPTMS, the peak attributed to the primary amine of PEG-diamine diminished, as coupling
proceeded between the two components to establish secondary amine linkages. Complete
organic-inorganic bioactive glass materials composed of coupled PEG-diamine, calcium, and
silica sol-gel precursors possessed decreasing characteristics of the organic PEG-diamine. This
led to the reduction in both -NH2 and -CH bending and the broadening of peaks associated to the
inorganic network such as Si-OH (780, 934 cm-1) and Si-O-Si (1065 cm-1). As expected, both
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completely inorganic materials composed of both bioactive glass and pure silicate networks did
not possess any peaks attributed to the inorganic network. Differences between the two networks
can be observed through their degree of condensation. The purely silicate network (formed by
hydrolyzing and condensing TEOS) had a stronger peak attributed to the condensed silicate
species (Si-O-Si). Indeed, this was expected as the calcium alkoxide used in this study (calcium
2-ethoxyethoxide) has fewer terminal sites (2) compared to that of TEOS (4). The integration of
Ca2EE was thus expected to decrease the network density, which has been well established to
also affect the dissolution rate of the inorganic bioactive glass materials41.

Figure 4.4 Infrared analyses of chemical structures in Si-Ca coating materials. Total reflectance
Fourier transform infrared (ATR-FTIR) spectra of PEG-diamine, PEG-diamine coupled
with 3-glycidyloxypropyltrimethoxysilane (PEG+GPTMS), hybrid coating material (SiCa-PEG), inorganic bioactive glass material (Si-Ca), and pure inorganic siloxane
(condensed TEOS). Peaks attributed to PEG-diamine (-NH2, -CH) were apparent for the
hybrid coating material and absent in purely inorganic coating materials. The chemical
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characteristics of the inorganic bioactive glass coating materials was similar to that of the
pure siloxane network with prominent Si-O-Si and Si-OH peaks.

Coating adhesion is an important factor in determining the clinical translatability of implant
coating materials. While overlooked in many studies, poor adhesive strength may lead to
delamination of coating materials which can cause inflammation, bone resorption, and to the
eventual failure of intraosseous implants in vivo51,52.
To quantitatively evaluate the adhesion of the hybrid bioactive glass coatings developed in this
study, adhesive tensile tests were performed based on established protocols42,53. Coatings were
evaluated for their adhesion to both polished and acid-etched Ti6Al4V substrates (Figure 4.6).
Hybrid bioactive glass coatings were significantly (p < 0.05) more adherent to acid-etched
Ti6Al4V than to polished Ti6Al4V substrates. Indeed, acid-etching, as with other surface
roughening pre-treatments, has been well established to increased the adherence of coating
materials54–56. This improvement in coating adhesion has been attributed to greater mechanical
adhesion due to the increase in bonding area that occurs during roughening pre-treatments.
While plasma-sprayed hydroxyapatite (HA) coating materials remain the gold standard for
intraosseous implants, their relative inconsistency and weakness has been the subject of many
studies. Their application, which include high temperatures and variable cooling cycles, are
known to retain residual stresses within these coating materials which can result in adhesive
failures below 10 MPa21,57,58. The robust adhesive characteristics of the developed hybrid
bioactive glass coating (15.1 ± 3.3 MPa) developed in this study, therefore, warrants further
study.

Figure 4.5 Scanning electron microscopy (SEM) of titanium (Ti6Al4V) substrates and coated
surfaces. Polished Ti6Al4V was flat with smoothly scalloped surfaces (A). Acid-etched
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Ti6Al4V had extensive surface fissures that created micro-scale roughness (B). Hybrid
bioactive glass coating (Si-Ca-PEG) films on acid-etched Ti6Al4V substrates retained
micro-topographical features and surface roughness (C).

Figure 4.6 Adhesive tensile strengths of coatings and chitosan on titanium (Ti6Al4V) substrates.
Hybrid bioactive glass (Si-Ca-PEG) coatings (n=3/surface) were significantly (p < 0.05)
more adherent to acid-etched Ti6Al4V substrates than they were to polished Ti6Al4V.* statistically significant difference

4.3.2 In Vitro Bioactivity
The promotion of bone growth is important in ensuring the fixation of metallic implants and
preventing events of aseptic loosening. Calcium integration within coating materials has been
identified as a key factor in the development of bioactive materials21,22. It was therefore
important to determine whether the low temperature integration of Ca2EE into the hybrid sol-gel
coating networks would render the hybrid coatings to be bioactive.
Evaluation of osteoconduction through in vitro immersion studies has been well established to be
indicative of actual osteoconduction and bone growth in vivo59,60. Therefore, in this study, the
mineralization of HA on hybrid coating surfaces was evaluated following 72 hours immersion in
simulated body fluid (SBF). To evaluate HA mineralization on hybrid coating materials, SEM
analysis and EDX maps were used (Figure 4.7). Following 3 days immersion in SBF,
characteristic globular HA deposits were found on the surface of hybrid coating materials
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(Figure 4.7-a). Indeed, EDX mapping confirmed the composition of globular deposits to be
hydroxyapatite through the presence of phosphate on the surface (Figure 4.7 (f)), and, the
elemental ratio of Ca/P of 1.6. While the elemental ratio of Ca/P is slightly below the theoretical
value of hydroxyapatite (Ca/P = 1.67) it is well within that of common apatite crystallites formed
by similar biomimetic processes61,62.
Further, EDX analysis confirmed the retention and homogeneous distribution of coating network
elements and imbedded AgNPs (Figure 4.7 b-e). Following 72 hours immersion, AgNPs
remained imbedded within the coating network and were not lost to dissolution.

Figure 4.7 Elemental EDX mapping analysis of the hybrid coating material (Si-Ca-PEG) after
72 hours immersion in SBF: (a) selected microscopic SEM field; (b) Si; (c) C; (d) Ag; (e)
Ca, and (f) P. SEM micrographs display the presence of apatite globules on the surface of
Si-Ca-PEG monoliths following immersion in SBF. Elemental analysis confirms the
presence of apatite. Scale bar: 100 µm.

4.3.3 Antimicrobial Properties
Infections due to microbial colonization on implant surfaces currently pose the highest risk to the
success of implantable prostheses6–8. Therefore, the application of antimicrobial coatings on
implant materials presents an effective strategy in mitigation IAIs.
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Further, the utilization of AgNPs within antimicrobial materials has garnered significant interest
due to their broad-spectrum effects, limited cytotoxicity, and ease of synthesis63,64. AgNPs
possess particular advantages as coating-loaded antimicrobial agents as they have shown efficacy
in mitigating the growth of bacteria in both static and planktonic cultures65–67.
Therefore, in this study, hybrid coatings were afforded with antimicrobial properties by
imbedding AgNPs within the hybrid coating networks. S. aureus and E. coli, clinically relevant
pathogenic bacteria, were selected as model bacterium to evaluate the antimicrobial efficacy of
developed coatings. The efficacy of such antimicrobial coatings was evaluated in both culture
and biofilm states.
In planktonic assays, hybrid coatings loaded with AgNPs showed effective inhibition of both
bacterial cultures compared to uncoated titanium controls (Figure 4.8). Both planktonic cultures
of E. coli and S. aureus were almost completely inhibited (90% and 82%, respectively) by hybrid
coating materials loaded with AgNPs and were significantly (p < 0.05) more effective in
mitigating microbial growth than base coatings (< 6%). Given the suspended nature of the
culture, these results indicated that imbedded AgNPs participated in release-based antimicrobial
action against both pathogenic bacteria.
Coating materials loaded with AgNPs, while effective at mitigating the growth of both model
bacteria in planktonic cultures, displayed greater efficacy against E. coli than S. aureus. The
differences in antimicrobial efficacy against both pathogenic bacteria can be owed to the
differences between Gram-negative and Gram-positive cell wall structures. Gram-positive
bacteria, such as S. aureus, possess much thicker peptidoglycan layers within their cell walls
compared to Gram-negative bacteria such as E. coli68. The thicker cell walls of Gram-positive
bacteria have been shown to limit the internalization of antimicrobial nanoparticles, and, have
shown a reported similar resistance to such antimicrobials compared to Gram-negative
bacteria69–71.
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Figure 4.8 Inhibition of bacterial cultures by Si-Ca-PEG coatings with (+) and without (−)
AgNPs. E. coli and S. aureus cultures were inhibited by incubation (24 hours) with
AgNP-loaded hybrid coatings, compared to uncoated titanium (Ti6Al4V) controls. There
was little inhibition from base coatings without AgNPs, but significantly (p < 0.05) more
and almost total inhibition for coatings loaded with AgNPs.

Due to the highly resistant nature of biofilms, their treatments remain minimally effective in the
clinic. For this reason, antimicrobial coatings are continuously sought to enable the localized
dislodgement or inhibition of biofilms on implant surfaces. Therefore, in addition to their
efficacy against suspended bacteria, hybrid coatings were assessed for their ability to mitigate the
formation of E. coli and S. aureus biofilms.
Both E. coli and S. aureus cultures were effectively inhibited by hybrid coatings containing
AgNPs compared to their uncoated Ti6Al4V controls (Figure 4.9). The biofilms formed by E.
coli and S. aureus were markedly inhibited (80% and 89%, respectively) by hybrid coatings
materials loaded with AgNPs and were significantly (p < 0.05) more effective at preventing
biofilm formation compared to base coatings (< 25%). Such results indicate the contact-active
and anti-adhesive nature of hybrid AgNP-loaded coatings against model sessile bacteria colonies.
In contrast to planktonic susceptibility, E. coli was less susceptible than S. aureus to
antimicrobial coating blends during biofilm assays. While these differences were insignificant
(p > 0.05) in our study, similar works have also found E. coli to be more resistant than other
Gram-positive bacteria to antimicrobial coatings in biofilm assays69,72. Such differences have
been owed to the rapid extracellular polymeric substance (EPS) formation of E. coli in their
sessile state, which has shown to be effective in resisting antibiofilm agents such as metal ions73.
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Figure 4.9 Inhibition of bacterial biofilm formation on hybrid coatings with (+) and without (−)
AgNPs. E. coli and S. aureus biofilm formation (24 hours) were inhibited on hybrid
coatings, compared to uncoated titanium (Ti6Al4V) controls. Inhibition of biofilm
formation was significantly greater (p < 0.05) on coatings that contained AgNPs. Hybrid
bioactive glass coatings were generally more effective than purely inorganic bioactive
glass coatings at inhibiting the formation of biofilms. The highest degree of biofilm
inhibition was observed for S. aureus biofilms on for both coatings that contained
AgNPs.

4.4 Conclusions
In this study, Si-Ca-PEG class II hybrid materials were developed as coating materials for
implantable Ti6Al4V substrates. To manifest antimicrobial properties, developed coatings were
loaded with AgNPs. Using 13C and 1H NMR, the synthesis of new precursor components was
confirmed. The chemical structure and topographies of developed coating materials was
evaluated using FTIR, SEM and EDX analysis. To evaluate the robustness of developed hybrid
coatings materials, adhesive tensile testing was preformed. The in vitro bioactivity of hybrid
coatings was assessed through their immersion in SBF and ability to induce the nucleation of
HA. The antimicrobial properties of developed coatings were evaluated in planktonic and
biofilm cultures of E. coli and S. aureus.
Coating precursors, including Ca2EE and PEG-diamine, were introduced into a hybrid bioactive
glass network for the first time. Their synthesis was confirmed using through the analysis of
relevant NMR data and consistency with relevant literature. Hybrid bioactive glass coatings
demonstrated robust resistance to delamination and were highly adherent to Ti6Al4V substrates.
Ti6Al4V substrates that were acid-etched demonstrated retained microtopographical roughness
and increased resistance to hybrid coating delamination. Hybrid coatings were able to promote
apatite mineralization in vitro, indicative of their potential to rapidly promote new bone
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regeneration and fixation in vivo. Additionally, hybrid coating materials loaded with AgNPs
showed significant inhibition of E. coli and S. aureus in both planktonic and biofilm states. The
highly adherent and multifunctional hybrid coating materials developed in this study affords a
novel strategy in mitigating the risks associate with implantable titanium materials.
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Chapter 5: General Discussion
5.1 Summary
The main objective of this study was to develop bioactive and biocompatible covalently coupled
(class-II) hybrid coating materials to mitigate the complications associated with titanium
implants. In this thesis, the synthesis and evaluation of two coatings systems were discussed.
First, in chapter 3, the synthesis of chitosan-silica hybrid coatings prepared through sol-gel
processing were presented. In this study, the inorganic network was composed exclusively of
silica and the organic network materials were comprised 3-glycidoxypropyl trimethoxysilane
(GPTMS) and chitosan. Developed hybrid coatings possessed improved robustness to control
inorganic silica coatings which have previously been shown to be brittle when cured at low
temperatures. Additionally, upon acid-etching Ti6Al4V substrates, all hybrid coatings possessed
improved adhesive properties and outperformed some clinically available hydroxyapatite-based
implant coating materials. By loading these hybrid materials with silver nanoparticles, coated
substrates were able to provide an effective resistance against both E. coli and S. aureus in
culture and adherent states.
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In chapter 4, the synthesis of novel polyethylene glycol-diamine-calcium-silica coatings prepared
through sol-gel processing were presented. In this study, the inorganic network was composed of
silica and newly synthesized calcium-2-ethoxyethoxide (Ca2EE) to afford the material with
greater bone-bioactivity. Here, the organic network was comprised of 3-glycidoxypropyl
trimethoxysilane (GPTMS) and PEG-diamine (2K). In this work, we provided a non-toxic
synthesis method for developing Ca2EE which has not yet seen use in the development of other
bioactive glass materials. The room temperature addition of calcium into the hybrid coating
network was successfully achieved using this new calcium alkoxide and promoted apatite
mineralization in vitro after only 3 days immersion in simulated body fluid (SBF). Developed
hybrid coatings were highly adherent to acid-etched Ti6Al4V substrates and outperformed that
of some clinically available hydroxyapatite-based implant coating materials described in other
studies. By loading these hybrid materials with silver nanoparticles, coated substrates were able
to provide effective antimicrobial action against both E. coli and S. aureus in both culture and
adherent states.
5.2 Contributions to current knowledge
For metallic implants, the synergistic risks of loosening and infection have been well established
since the 1980s1. Despite this, aseptic loosening and implant associated infections continue to
plague hard tissue implants and limit their success in the clinic. In this thesis work, we provide
two feasible coating systems which can be utilized to improve the success of metallic implants.
In the study of both coating materials, delamination protocols were followed to better evaluate
the robustness of the developed hybrid coating materials. Such tensile adhesion pull-tests have
not yet been preformed on similar hybrid materials to the ones described in this work. These
results can provide a much-needed baseline to assess the robustness of other such coatings which
may be used for metallic implant materials.
This study also evaluated the contact and release-based antimicrobial action of silver
nanoparticles imbedded within hybrid coating materials. While other studies typically assess the
antimicrobial action of such coatings through either release-based (Kirby-Bauer) or contactbased (biofilm) assays, we evaluated the antimicrobial action of our coating in both domains.
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These results will ideally emphasize the importance of both antimicrobial strategies in the
development of effective antibacterial implant coatings.
Lastly, in chapter 4, the novel non-toxic synthesis of calcium-2-ethoxyethoxide (Ca2EE) is
proposed, and, for the first time, used in the synthesis a bioactive glass material. In this work,
synthesized Ca2EE displayed stability in water-containing sol-gel systems and was able to be
homogeneously introduced into hybrid coating material networks at low temperatures. By
providing the synthesis and network integration protocol for Ca2EE, other researchers may use
this sol precursor to develop other bioactive materials that can be cured at low temperatures,
enabling the inclusion of temperature sensitive components.
5.3 Limitations and Suggestions for Future Work
Through this work, sol-gel derived hybrid coatings on Ti6Al4V substrates were preliminarily
examined. While the materials developed in this study displayed favourable results in improving
the lifetime of metallic implants, more experimental works are suggested before this coating
technology could be transferred to the clinic. Therefore, the following limitations of this study
are discussed below, with appropriate recommendations for future works.
While coated substrates displayed a high degree of robustness and resistance to delamination,
more detailed experimentation could be conducted to further evaluate the physical properties of
coating materials. For example, the thickness of the coating materials could be further evaluated
using advanced SEM/TEM techniques to better evaluate the effect of dipping speed, the
adherence characteristics of modified coatings, and the effect of relevant substrate pretreatments. Additionally, as roughness and porosity are important parameters in determining the
cellular response to biomaterials, quantitative measurements to evaluate coating topographies
(such as atomic force microscopy) should be used in place of the qualitative SEM descriptions
provided in this work. Lastly, while the robustness of developed coating materials was evaluated
in a quantitative manner, additional clinically relevant assessments could be preformed. For
example, the resistance of coating materials to fracture or delamination in a more clinical setting
could be evaluated by coating titanium dental screws and preforming pseudo-implantation and
removal in a model bone material2.
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Another limitation to this study is the absence of release and degradation-based data of
developed coating materials. For future works it is recommended that elemental release data be
collected (using inductively coupled plasma mass spectroscopy) in relevant solutions (preferably
simulated body fluid). This data could be used to better evaluate how the hybrid coating
materials degrade, and, assess if there is any inhomogeneous degradation of coating components.
Additionally, using ICP-MS, the mineralization of apatite on hybrid coating surfaces could be
quantified over time which could be used to compare the in vitro bioactivity of a variety of
modified and control surfaces.
Lastly, one major limitation to this study is that cell culture or in vivo studies were not preformed
on developed coating materials. Although developed coatings displayed favourable signs for cell
viability (microroughness, hydrophilicity, etc.), relevant cytotoxicity and proliferation assays
should be preformed to better assess their in vivo compatibility. In general, cell attachment and
proliferation studies are necessary to determine the cellular metabolic activity and osteoinductive
of developed hybrid coatings to ensure that they are indeed biocompatible3.
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